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“Beautiful is better than ugly. 
Explicit is better than implicit. 
Simple is better than complex. 
Complex is better than complicated. 
Flat is better than nested. 
Sparse is better than dense. 
Readability counts. 
Special cases aren't special enough to break the rules. 
Although practicality beats purity. 
Errors should never pass silently. 
Unless explicitly silenced. 
In the face of ambiguity, refuse the temptation to guess. 
There should be one—and preferably only one—obvious way to do it. 
Although that way may not be obvious at first unless you're Dutch. 
Now is better than never. 
Although never is often better than right now. 
If the implementation is hard to explain, it's a bad idea. 
If the implementation is easy to explain, it may be a good idea. 
Namespaces are one honking great idea—let's do more of those!” 
“Zen of Python” by Tim Peters, Software engineer 
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The complex Gram-negative bacterial cell envelope is an important factor of intrinsic 
and acquired antibiotic resistance and explains the limited treatment options for 
infections caused by such pathogens.  
To support the discovery of highly permeating and thus potentially more active 
compounds, in vitro models based on permeable well plate inserts have been 
developed, advanced, and characterized.   
Advancing an approach by F. Graef1, which mimics the total envelope structure of 
Gram-negative bacteria, similarities to the actual cell envelope structure have been 
revealed by CLSM and x-ray microtomography. Commercially available antibiotics 
have been tested with nalidixic acid permeating fastest.   
A second model was obtained by exploring if polysaccharide gels allow to distinguish 
high from low accumulating antibiotics. With 20 % (w/v) starch gel performing best, the 
preparation was automated, structure-permeation relationships investigated and 
validated by machine learning.  
A third model is based on extracellular vesicles of Escherichia coli. These vesicles and 
the model derived thereof have been characterized by electron microscopy, while the 
performance of the model was investigated by comparing in vitro data to in bacterio 
accumulation and to permeability data from liposome-based models.  
Lacking porins, the total envelope model was limited to predict porin-independent 












Die Zellmembran gramnegativer Bakterien ein wichtiger Faktor für intrinsische und 
erworbene Antibiotikaresistenzen. Um die Entdeckung von gut permeierenden und 
folglich potenziell wirksameren Antibiotika zu fördern, wurden in vitro-Modelle 
basierend auf Wellplatten mit durchlässiger Membran (weiter-)entwickelt und 
charakterisiert.  
Bei der Weiterentwicklung eines Ansatzes von Gräf et al.1, der die Gesamtstruktur der 
gramnegativen Zellmembran nachbildet, wurde die Ähnlichkeit zum tatsächlichen 
gramnegativen Membranaufbau durch CLSM und Röntgenmikrotomographie 
festgestellt. Kommerziell erhältliche Antibiotika wurden getestet, wobei Nalidixinsäure 
am schnellsten permeierte.  
Ein zweites Modell wurde erhalten, als explorativ untersucht wurde, ob 
Polysaccharidgele im Stande sind, gute von schlechtakkumulierenden Antibiotika zu 
unterscheiden. Mit 20%igem (m/v) Stärkegel, welches am besten abschnitt, wurde die 
Modellherstellung automatisiert, Struktur-Wirkungsbeziehungen untersucht und diese 
durch maschinelles Lernen validiert.  
Ein drittes Modell basiert auf extrazellulären Vesikeln von Escherichia coli. Die Vesikel 
und das Modell wurden durch Elektronenmikroskopie charakterisiert, während die 
Leistung durch Vergleich der erhaltenen Permeabilitätsdaten Daten mit bakteriellen 
Akkumulationsdaten und Permebilitätsdaten von liposomenbasierten Modellen 
überprüft wurde.  
Durch die fehlenden Porine im ersten Ansatz war dieser lediglich auf die Vorhersage 
von porinunabhängiger Permeation beschränkt. Die Vorhersage von porinabhängiger 







%IncMSE  relative increase of mean squared error in % 
AMP   ampicillin 
AZT   aztreonam 
ca.    circa 
CEF   cefuroxime 
CHL   chloramphenicol 
CIP   ciprofloxacin 
CL   1,1',2,2'-tetra-(9Z-octadecenoyl) cardiolipin (sodium salt) 
CLI   clindamycin 
clogDpH7.4  distribution coefficient at pH 7.4 
CLSM   confocal laser scanning microscopy 
Da   Dalton, non-SI unit for molecular weight 
DESY   Deutsches Elektronensynchrotron 
DMSO  dimethylsulfoxide 
DNA   Desoxyribonucleic acid 
ERY   erythromycin 
FITC   fluorescein isothiocyanate 
FUS   fusidic acid 
HPLC   high performance liquid chromatography 
IL   inner leaflet 
IM   inner membrane 
IMI   imipenem 
KAN   kanamycin 
KRB   Krebs-Ringer buffer 
X 
 
LC   liquid chromatography 
LEV   levofloxacin 
LIN   lincomycin  
LogP   Common logarithm of the octanol water partition coefficient 
magn.   magnification 
MD   molecular dynamics simulation 
MDCK  Madin Darby canine kidney cell line 
MIC   minimum inhibitory concentration 
MIN   minocycline 
MS   mass spectrometry 
NOR   norfloxacin 
NOV   novobiocin 
NXD   nalidixic acid 
OD600   optical density at 600 nm 
OL   outer leaflet 
OM   outer membrane 
Omp   outer membrane protein 
PAGE   polyacrylic acid gel electrophoresis 
Papp   apparent permeability coefficient 
PBS   phosphate-buffered saline 
PIP   pipemidic acid 
PM   plasma membrane 
PMF   proton motif force 
POPE   1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-p  




rac-glycerol) (sodium salt) 
PS periplasmic space 
PSA polar surface area 
PVPA Phospholipid vesicle-based permeation assay 
QCM-D Quartz Crystal Microbalance and Dissipation 
resp.  respectively 
RF Random forest analysis 
RIF   rifampicin 
RNA   ribonucleic acid 
Rt   retention time 
SDS   sodium dodecyl sulfate 
SE   standard error of the mean 
SEM   scanning electron microscopy 
SI   Système international d'unités, international unit system 
SPA   sparfloxacin 
STR   streptomycin 
SUL   sulfamethoxazole 
TCA   trichloroacetic acid 
TEM   transmission electron microscopy 
TET   tetracycline 
TIG   tigecycline 
TOB   tobramycin 
TOMAS  Titrable Outer Membrane Permeability Assay System 
UHPLC  ultra-high performance liquid chromatography 
VAN   vancomycin
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1. General introduction – State-of-the-art 
 
1.1 The composition of the Gram-negative bacterial cell envelope in comparison 
to Gram-positive and mammalian cells as well as their standard organelles 
 
A comparative look at the membrane structures of Gram-negative, Gram-positive and 
mammalian cells reveals significant differences. However, when looking close, unexpected 
similarities occur. Figure 1 illustrates the membrane architecture of Gram-negative, Gram-
positive, and mammalian cells. Starting with the plasma membrane (PM), similarities between 
Gram-positive and Gram-negative bacteria and differences to mammalian cells become 
obvious. In contrast to mammalian cell membranes, which contain primarily 
phosphatidylcholines (PC) and phosphatidylethanolamines (PE), the main phospholipids of the 
bacterial membranes are PE, phosphatidylglycerols (PG) and cardiolipin (CL), whereas the 
quantitative composition of these phospholipids is strongly species-dependent2,3. Generally, 
PMs feature membrane receptors, proteins maintaining membrane stability and regulating the 
uptake of nutrients and electrolytes or acting as enzymes4–7. Mammalian PMs, in addition, 
feature proteins for cell-to-cell adhesion, direct intercellular nutrient transfer, receptors with 
immune functions and ion pumps for the maintenance of the membrane potential5,8. Bacteria 
also create a membrane potential. This is caused by proteins of the respiratory chain, which are 
located directly in the PM9,10. In the case of Gram-negative bacteria, this respiratory chain 
creates a distinct proton gradient between the periplasmic space and the cytoplasm. This 
gradient creates the so-called proton motif force (PMF) and is known to be involved in the uptake 
of aminoglycosides from the PS across the PM into the cytoplasm11,12.  
Whereas mammalian cells are only bordered by a plasma membrane (PM), Gram-negative and 
Gram-positive cells feature a combination of PM and cell wall. This cell-wall giving cell stability 
is composed of a peptidoglycan layer, which is much thicker in Gram-positive than Gram-
negative bacteria13. Moreover Gram-positive cell walls contain cell wall-associated proteins (for 
example LPXTG proteins, and CWBD proteins), resistance related enzymes such as -
















Figure 1. Membrane structure of Gram-negative, Gram-positive and mammalian cells. The cell envelope of 
Gram-negative bacteria comprises three major compartments: outer membrane (OM), inner membrane (IM) and 
the periplasmic space (PS) between both membranes containing a peptidoglycan layer (PG). Peptidoglycan layer 
and outer membrane are regarded as Gram-negative cell wall15. The OM features lipopolysaccharides (LPS) at its 
outer leaflet and phospholipids at its inner leaflet. OM proteins, such as channel proteins (porins), OM efflux 
proteins and proteins involved in active uptake mechanisms are embedded. The IM is a symmetric16 phospholipid 
layer providing internal support17 and features efflux pumps, transport proteins and protein complexes of the energy 
related metabolism9. Gram-positive bacteria have a peptidoglycan layer surrounding the plasma membrane (PM). 
Some Gram-positive and -negative species, are surrounded by a surface layer (S-layer)18. Mammalian membranes 
only consist of a PM with channel, receptor and efflux proteins embedded and polysaccharide chains attached to 
it forming the glycocalyx. 
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Like Gram-positive species, resistance related enzymes of Gram-negative bacteria, can also be 
found alongside the peptidoglycan layer. However, in Gram-negative bacteria, the outer 
membrane (OM) separates these enzymes and peptidoglycan from the extracellular 
environment and thus forms an additional compartment: the periplasmic space. This 
compartment is highly viscous and contains in addition to enzymes and peptidoglycan high 
concentrations of electrolytes, structural proteins, transport proteins, amino acids19.  
The aforementioned asymmetric OM of Gram-negative bacteria can be subdivided into an outer 
leaflet (OL) composed of lipopolysaccharides (LPS) and an inner leaflet (IL) composed of 
phospholipids. More or less specific porin channels embedded in the OM grant a certain degree 
of access to small polar compounds20. Other outer membrane proteins are related to active 
compound uptake (TonB-dependent transporters, e.g. BtuB, FhuA, FepA21), virulence (OmpX22, 
OmpA23, flagellin24), metabolism (OmpT25, OmpP26) and structural maintenance(OmpA27, 
nlpB28). In Gram-positive bacteria, these processes are usually covered by proteins of the PM14.  
In contrast to the uniqueness of the OM asymmetry in Gram-negative bacteria, the three-layered 
structure of their envelopes can also be found within eukaryotic cells, namely in mitochondria, 
nuclei and chloroplasts.   
By looking closer, further similarities become obvious particularly for mitochondria. The proteins 
of the respiratory chain, located in the Gram-negative inner membrane can also be found in the 
inner membrane of mitochondria and pore proteins, similar to the Gram-negative outer 
membrane, can be found on the mitochondrial outer membrane. In addition, mitochondria shed 
outer membrane vesicles like Gram-negative bacteria and the typical Gram-negative 
phospholipids PE, PG and CL are present. These similarities do not only remarkably 
demonstrate the Gram-negative origin of mitochondria and the endosymbiotic theory; this fact 
should probably be more intensely considered in future to reduce side effects of antibiotics.  
A general similarity between mammalian and bacterial membranes is the presence of 
membrane fluidity regulating molecules. While cholesterol is found in mammalian cell 
membranes, so-called hopanoids facilitate this task in bacteria29. Both are mainly saturated 







1.2 The Gram-negative bacterial cell envelope as cause for antibiotic resistance 
 
Different factors are known to cause antibiotic resistance. Apart from mutations at binding sites 
of intracellular targets33 and degrading enzymes located in the cytoplasm34, most of the activity-
affecting entities are apparently associated with the cell envelope. This holds true for efflux 
pumps, -lactamases and the outer membrane proteins.   
Porins can be currently regarded as the main entrance route for antibiotics active in many 
pathologically relevant Gram-negative bacteria. As shown in Table 1, the most abundant porins 
in Acinetobacter baumannii, E. coli, Klebsiella pneumoniae, Salmonella typhimurium seem to 
have a molecular weight cut-off of 500-700 Da. However, even within a single porin, the cut-off 
should never be considered as an absolute limit, since various physicochemical properties of 
the permeating molecule as well as the electrostatic interactions with the porin and its 
fluctuations in diameter also play a significant role35.  
Besides, it is important to realize that cut-off numbers not always give a hint to the degree of 
molecular translocation across porins.  Although OprF in P. aeruginosa is known to be the most 
abundant outer membrane protein, which even allows for compounds as large as 3 kDa to 
permeate, is was found that the permeation speed is generally low36. OmpAab in A. baumannii 
also shows remarkably slow permeation37. The selectivity of porins and deceleration of 
permeation velocity may account for the intrinsic resistance of Gram-negative species to a broad 
number of antibiotic classes, such as macrolides, glycopeptides, ansamycins, lincosamides and 
steroid antibiotics. Furthermore, Gram-negative bacteria can also acquire resistance by 
downregulating porin expression, as has been reported for OmpF in E. coli38 OprD in P. 
aeruginosa39 and OmpK35 and OmpK36 in K. pneumoniae40. It must be mentioned that the 
above discussed porins in spite of their general selectivity for rather small and hydrophilic 
molecules are regarded as unspecific porins. Porins, for example LamB (passive transport of 
maltose, malto-oligosaccharides) and Tsx (passive transport of nucleosides, deoxynucleosides) 
in E. coli have a much higher substrate specificity and are thus termed “specific porins”. Among 
those, so-called ligand-gated channels, for example FadL (passive transport of long fatty acids, 
E. coli and others) and CymA (passive transport of -cyclodextrins, Klebsiella oxytoca) even 
open only in the presence of their substrate19.   
Enzymes in the periplasm can also be related to antimicrobial resistance. -lactamases are the 
most common, very versatile (almost 2800 unique proteins) and evolutionary adaption has 
hitherto constantly succeeded in hydrolysing the -lactam ring of every new generation of -
lactam antibiotics including carbapenems and monobactams41,42. In Gram-negative bacteria, 
extended spectrum -lactamases, serine carbapenemases and metallo--lactamases are 
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among the most frequent causes of -lactam resistance.  
 
Table 1. Selection of outer membrane proteins with channel function (“porins”). n.r.: not reported 
Species Porin Molecular weight cut-off Selectivity 
Acinetobacter 
baumannii 
OmpA ~500 Da37 Non-selective37  
Escherichia coli OmpF ~600-70043 slightly cation selective44 
OmpC ~600-70043 Non-selective44 
PhoE n.r. Anion selective44 
Klebsiella 
pneumoniae 
OmpK35 Similar to OmpF45 Similar to OmpF, less selective 
towards larger, lipophilic molecules45 
OmpK36 Similar to OmpC45 Similar to OmpC45 
Pseudomonas 
aeruginosa 
OprF ~300046 Non-selective47 
OprD n.r. Basic amino acids, small peptides, 
Carbapenems39 




OmpF ~60048 Non-selective31 
 
Furthermore, the accumulation of antibiotics at the target site can be reduced by efflux pumps. 
Their protein complex spans over the entire cell envelope. The AcrAB-TolC complex is the most 
prominent one in E. coli. MexAB-OprM, MexCD-OprJ and MexXY-OprM are the dominant efflux 
pumps in Pseudomonas aeruginosa, whereas AdeABC are typically found in A. baumannii49. 
The selectivity of E. coli and P. aeruginosa efflux was previously studied by Astra Zeneca, 
indicating that molecules are less likely to undergo efflux when small (<450 Da) and highly 
charged50.  Other reports emphasize species specific differences of physicochemical 
properties making molecules prone to efflux51.  Table 2 summarizes the main uptake pathway, 
metabolic modifications and reported efflux pathways of antibiotic classes commonly used to 
treat infections by Gram-negative bacteria.  
Efflux pumps have also been reported for Gram-positive bacteria52 and mammalian cells53, and 





Table 2. Established antibiotics for the treatment of Gram-negative bacterial diseases, selected 
physicochemical properties, major uptake pathways and metabolic modifications  
Name Example  














- clogD7.4 –8.1[a] 




















- clogD7.4 0.86[c] 
- MW 323 Da 
- T[b] 









- clogD7.4 –2.4[a] 
- MW 413 Da[a] 














- clogD7.4 –3[a] 
- MW 452 Da[a] 










- clogD7.4 –5.8[a] 
- MW 397 Da[a] 














- clogD7.4 –2.8[c] 
- MW 423 Da[d] 













- clogD7.4 –0.8[a] 
- MW 371 Da[a] 












- clogD7.4 –3.6[a] 
- MW 481 Da[a] 
- T, (R)[b] 
Porin 
outer 













- clogD7.4 –3.2[c]  













- clogD7.4 –0.1[a] 
- MW 273 Da[a] 



















- clogD7.4 2.9[c] 





 (proteolysis)78 - 
[a] Average values reported by O’Shea and Moser.79 [b] The fulfilment of eNTRy rules.80,81 N = ionisable amine, T = low three dimensionality, R = rigidity.  
[c] Values generated by StarDrop v. 6.6.1.22652, [d] Values generated by StarDrop 6.6.4.23412; the antibiotic panel used for [b] and [c] is listed in appendix 7.1, 
MW = molecular weight, n.r. = not reported
8 
 
1.3 Experimental determination of membrane permeability 
 
The amount of substance (n) that diffuses across a defined surface area (A) in a certain 
time interval (t) is called flux (J). According to Fick’s first law, the flux is dependent on 
the diffusion coefficient (D), the distance of the diffusion (s) and the concentration 








Permeability is defined as the motion of a substance across a membrane82. It can be 
studied for example by static systems such as Franz cells or coated Transwells®, 
consisting of a donor compartment and an acceptor compartment, which is divided by 
a membrane. Since those systems consist of an interface of two materials, the partition 
coefficient (Kp) of the respective combination of materials plays an additional role 
(Equation 2).   




Here, s stands for the thickness of the membrane, since the particle motion across this 
is material is considered as the major diffusion delimiting step. (Fig. 2) 
 
Figure 2. Concentration profile within a typical static experimental set-up to determine 
compound permeability. Because of the higher concentration in the donor compartment, 
particles move towards the acceptor compartment, separated by a membrane with the defined 
thickness s. Over the course of time, concentrations in both compartments will reach an equal 
level (ceq). 
 
[mol*m-2*s-1 ] (2) 




The diffusion coefficient D depends on the viscosity (), temperature (T) and the 




6𝜋 ∗  ∗ 𝑟
 
D = diffusion coefficient 
kB= Boltzmann constant (1.380649*10−23 J*K-1) 
T = absolute temperature 
 = viscosity 
r = hydrodynamic diameter of diffusing particle 
 
Hence, the viscosity and temperature should be kept constant throughout the entire 
permeation experiment. The hydrodynamic diameter indicates that larger particles are 
likely to move slower than smaller particles, regardless of equal concentration or choice 
of diffusion barrier.  
If the membrane thickness remains the same in all experiments, s, D and Kp can be 
simplified to one coefficient “P” - the permeability coefficient (Equation 4). This is a 
value, which is characteristic for every diffusing particle and biphasic system. Hence it 
can be for example used to either compare particle permeability while not altering the 
biphasic system or to compare biphasic systems, while using the same kind of particle.  
 
𝐽 = 𝑃 ∗ 𝑐 
 
To further simplify experimental conditions for permeability studies, so-called sink 
conditions are assumed. Normally, sink conditions are achieved by continuous removal 
of the permeated compound to maintain a maximum concentration gradient. In a closed 
and static system, sink conditions describe that the particle concentration in the donor 
compartment is at least ten times higher than in the acceptor compartment. Under 
these conditions the concentration in the acceptor compartment can be neglected. The 
concentration gradient remains virtually the same throughout this phase, is equal to the 
initial particle concentration (c0) in the donor compartment, and does not depend on 
time (Equation 5, 6). 












J can be determined experimentally by taking samples at defined amounts of time, 
determining the particle concentration, and based on that calculating the permeated 
amount (n). This amount is then divided by the membrane surface area (A) and the 
respective time interval (t). The most robust way is to perform a linear regression over 
several time intervals (Fig. 3) and divide the slope of the obtained regression function 
by the membrane surface area.  
 
Figure 3. Permeation-time course of a typical transport experiment under static 
conditions. Permeated amounts at defined time intervals are plotted cumulatively over time. 
Often, a lag time can be observed (Phase I), in which the compound enriches inside the 
membrane. After the membrane is saturated with the compound, a second phase (II) starts, in 
which the permeated amount increases linearly, since the concentration gradient remains still 
close to the maximum (sink conditions). There, a linear regression can be performed. It yields 
the regression function (dashed line) y = mt + z. To obtain the flux (J), the slope m is divided 
by the membrane surface area. At the end of the transport experiment a phase III starts, in 
which the compound accumulation in the acceptor compartment decreases, as a result of the 
decreasing concentration gradient. It approaches ceq (Fig. 2) asymptotically. 
 
Notably, the units of the permeability coefficient are the same as for the velocity. Hence, 
the permeability coefficient can be regarded as the velocity of the molecule or particle, 
resp., while it is crossing the membrane. In this thesis, the term apparent permeability 
coefficient (Papp) is used, since the “true” permeability coefficient is experimentally not 
accessible. Experimental imperfections are the assumption of sink conditions in a static 
set-up, variations in membrane thickness, shifts in temperature, compound adhesion, 
degradation, electrostatic interactions between the permeating compounds, 




1.4 Overview, comparison, and evaluation of assays to study factors of 
bacterial bioavailability 
 
1.4.1 Cell-based assays 
 
The study of compound accumulation in cells, generally follows three principles: i) 
quantification of the decrease of concentration in the bacterial suspension medium 
(Fig. 4 A), ii) quantification of the compound accumulation within living bacteria (Fig. 4 
B) or iii) quantification of the accumulated compound after lysing the bacteria (Fig. 4 
C).  Decad et al. was the first to determine the permeability across the outer membrane 
of the Gram-negative bacteria E. coli and S. typhimurium83. Instead of using antibiotics, 
however, they employed radiolabeled oligosaccharides of different molecular weight, 
incubated them with the respective bacteria and measured the radioactivity of the 
bacterial pellet after centrifugation.  
Nikaido later determined the accumulation-time course of different antibiotics indirectly 
by incubating bacteria with an antibiotic solution and determining the decrease of 
antibiotic concentration in the supernatant by spectrophotometry84. Only recently the 
same principle has been reported again using LC–MS for quantification85 and still 
requires further validation and upscaling efforts.  
Rosselet and Zimmermann investigated a so-called “permeability parameter” 
(comparable to the flux in Fick’s laws) of antibiotics on E. coli 205 by determining the 
velocity of -lactam hydrolysis within intact bacteria and bacterial lysate. They 
hypothesized a rapid formation of a steady state, at which the diffusion rate of -
lactams across the outer membrane of E. coli equals the velocity of -lactam hydrolysis.  
The group of Chapman and Georgopapadakou first reported the measurement of 
antibiotic accumulation in E. coli by employing fluorometry, a comparably fast method 
being less sensitive than radioactivity quantification, but sensitive enough to measure 
the uptake of fluoroquinolones at therapeutic concentrations. Piddock et al. extended 
the application to other bacterial strains and species including P. aeruginosa86–90. In 
addition, Vergalli et al. reported three methods for studying the antibiotic permeation 
covering different aspects91, whereas two of the methods employ fluorescence 
microscopic techniques. Using fluorescence microscopy allows for studying the 
permeation time course of intrabacterial antibiotic accumulation in single living cells. 
However, since bacteria are small organisms to investigate, usually synchrotron 
radiation is required as a source for the generation of deep ultraviolet light. This makes 
investigations rather sophisticated and not applicable on a regular base. Fluorometric 
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methods may, however, become more popular in near future, since they can be 
employed to study the uptake of emerging nano-scaled antimicrobial agents, such as 
phages, nucleic acids and antibodies. Considering their comparably large size, the 
conjugation with fluorescent probes is not expected to lead to a significant impact in 
permeation. An alternative reported technique not depending on fluorescence is 
RAMAN-microscopy92. Furthermore these microscopic techniques cannot only be 
applied to genuine cells but also to spheroplasts80,93. Their size can be increased by 
fusion with liposomes, which would make microscopic methods easier.   
More recently, other in bacterio assays have been employed detecting the 
accumulated amount after bacterial lysis by liquid chromatography-coupled mass 
spectrometry (LC–MS)80,94,95. The use of LC–MS makes it possible to investigate the 
accumulation of a large variety of antibiotics. Prochnow et al. was even able to further 
differentiate between the accumulations in different bacterial compartments. However, 
covalent binding to intracellular structures and bacterial metabolism may change the 
molecular weight and lead to underestimation of the actual accumulated drug. Such 
drug candidates typically are -lactams80, aminoglycosides96 and phosphomycin73.  
The speed of quantification is steadily increasing. Lately, a fast SPE–MS method was 
developed with an analysis time of 9 s per sample97. LC–MS can be considered as a 
gold standard to study accumulation. The effort in experimental preparation and 
sample purification, however, must still not be underestimated.   
Systematic knock-out and stimulus-triggered expression of proteins involved in specific 
uptake and efflux can also make it possible to compare minimum inhibitory 
concentrations of different antibiotics and allow for studies on structure–permeation 
relationships, as shown by the Titrable Outer Membrane Permeability Assay System 
(TOMAS)98. 
Overall, whole-cell assays are recommended as reference systems to directly measure 
the accumulation of antibiotics, because they also cover active uptake and efflux 
processes. Studies can be performed on specific strains and clinical isolates. Blocking 
or knock-out of diverse uptake, degradation and efflux mechanisms moreover allows 
investigation of the specific factors involved in antimicrobial accumulation. Assays with 




1. Even little knockout mutations in the bacterial genome may lead to a 
fundamental shift in protein expression, potentially leading to a fundamental 
change in outer membrane composition, as shown on E.coli TolC mutants100. 
2. Using so-called “chemosensitizers” (e.g. enzyme inhibitors or efflux inhibitors, 
such as carbonyl cyanide m-chlorophenylhydrazine101) can either lack 
specificity and/or unintentionally interfere with other bacterial processes. 
3. Living organisms undergo continuous adaptations to their environment. Small 
deviations in the experimental protocol have severe effects on reproducibility. 
4. Relevant bacterial species for antibiotic research are usually infectious and thus 
hazardous. Special facilities are needed to fulfil safety regulations and to protect 
the experimenter and the environment.  
 
Hence, alternative cell-free and computational approaches emerged to study very 
specific pathways and to make investigations faster and easier. 
 
1.4.2 Cell-free assays 
 
1.4.2.1 Vesicle-swelling assays 
 
Alternative cell-free approaches emerged to study specific pathways and to make 
investigations more distinct, faster, and easier. Nikaido followed the hypothesis that the 
access of most anti-infective compounds is controlled by porins44. He proved this 
hypothesis for glycosides as well as for several -lactam antibiotics, by creating 
proteoliposomes containing the OmpF59 and other porins. The uptake of the 
investigated substances happened indirectly by investigating the increase in vesicular 
size caused by the osmosis driven permeation of molecules into the vesicles. This so-
called vesicle swelling assay (Fig. 4 D) allows for specific permeability studies on 
different porins. It would be worth investigating if the vesicular swelling can be 
monitored by turbidimetry instead of dynamic light scattering. If successful, this 
technique can enable the liposome swelling assay to be used to screen compound 
libraries on 96 or more well plates. The isolation and purification of proteins may, 
however, be a bottleneck for this approach. This approach appears to be only 
applicable for compounds with good solubility, because only then the necessary higher 
osmotic gradients can be created. Ferreira and Kasson, therefore, used outer 
membrane vesicles of the wild type strain E. coli K-12 MG1655 instead. These naturally 
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shed bacterial extracellular vesicles usually contain a wide range of porins and feature 
an asymmetric membrane as in the actual OM. The vesicle swelling for the different 
tested antibiotics correlated with the permeability through OmpF calculated from 
molecular dynamics simulations. However the high standard deviation makes 
conclusions about antibiotic permeability and accumulation difficult102. Transferring this 
approach to other species cannot be generally recommended, since, as in the case of 
e.g. P. aeruginosa for example, the membrane composition of OMVs does not always 
represent the outer membrane composition of the bacterium they originate from103.
   
Nakae and Ishii also employed membrane vesicles for their studies. These were 
reconstituted from lysed Salmonellae104. The accumulated amounts within these 
vesicles were quantified directly by radiometry after radiolabeling the investigated 
compounds.   
     
1.4.2.2 Electrophysiological assays 
 
Taking the principle of so-called “patch clamp”-assays on Gram-negative bacterial 
membranes105, electrophysiological methods were developed to study the blocking 
events of bacterial porins106 (Fig. 4 E), which were integrated in an artificial free floating 
phospholipid bilayer (“black lipid membranes”107,108). Schindler and Rosenbusch 
investigated the permeation of sugars across the LamB porin of E. coli109. Nestorovich 
et al. used this setup first to study the interactions of an antibiotic (ampicillin) with a 
bacterial porin (OmpF)110. Electrophysiological studies performed in this fashion, 
however, lacked of evidence that blocking events on the membrane channels were 
correlated to actual molecular translocation across the membrane111. Just recently, 
Jiajun Wang et al., could introduce OmpF channels featuring a cystein moiety that acts 
as a counter for permeated molecules. Molecules that permeated will undergo retention 
at this additional narrow passage, which leads to an extended time of current drops112. 
Most recently, electrophysiological studies were also performed on membranes after 
fusion with outer membrane vesicles113.   
Using the electrophysiological approach leads to molecule-resolved studies of 
permeation events. By looking at the length and frequency of current drops one can 
estimate the extent of antibiotic translocation and speculate about possible molecule-
to-porin interactions. Studies like this are generally possible with any antibiotic, 
however, the application of voltage, particularly on charged molecules, leads to a 
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charge-dependent molecular migration. This is not representative for the concentration 
driven permeation of molecules, hence making it difficult to compare permeabilities 
between antibiotics. 
 
1.4.2.3 PVPA-like assays 
  
Another approach, which is of most importance for this dissertation is based on a so-
called phospholipid vesicle-based permeation assay (PVPA), developed by Flaten et 
al.3,114–116 a similar assay was developed using liposomes composed of phospholipids 
representative for E. coli. These liposomes were fused on top of a Transwell®-filter 
support117. Transwells® and other filter plates are usually employed for cell cultures. 
They consist of two compartments surrounding the (usually individually coated) filter 
support. For permeation studies, the donor compartment contains the drug solution 
and the acceptor compartment plain buffer. This creates a concentration gradient 
forcing molecules to permeate from the donor compartment across the filter membrane 
into the acceptor compartment (Fig. 4 F). The molecule concentration in the acceptor 
compartment increases and can be monitored by drawing and quantifying samples at 
desired time intervals. The resulting permeated amounts at defined time points as well 
as the velocity of the increase of concentration can be compared between different 
molecules, e.g. antibiotics. Encouraged by results obtained with the phospholipid-
based membrane model. Graef et al. enhanced the complexity of the model, by 
additionally coating a hydrogel, further phospholipids and LPS consecutively on top of 
each other in order to represent the entire multi-layered Gram-negative bacterial cell 
envelope. Whereas this model showed consistent results for molecules smaller than 
300 Da, permeation data obtained for compounds larger than 300 Da were only 
consistent for antibiotics following porin independent passive permeation. The overall 
permeation of compounds larger than 300 Da was rather low, whereas compounds 
smaller than 300 Da showed a size and logP dependent correlation with their 
permeability. This is typical of a porin-less permeation model and is in agreement with 
previous notions11.  
 
1.4.2.4 Efflux assays 
 
Efflux as another important factor has so far not been extensively studied in cell-free 
assays. Notably, studies on this type of transport are much more challenging, since it 
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is an energy dependent – proton motive force driven – one, which depends on a 
complex of proteins. Zgurskaya and Nikaido created special proteoliposomes, 
containing fluorescing phospholipids within their membrane118. These proteoliposomes 
had the AcrAB pumping complex of E. coli embedded in their membrane. Moreover, 
they were loaded with another fluorescent phospholipid. These proteoliposomes were 
assembled with unlabelled, unloaded liposomes. By creating a proton gradient across 
the liposomal membrane, they could activate the pumping complex, which then 
pumped the fluorescent cargo from the proteoliposomes into the plain unlabelled 
liposomes. The decrease of fluorescent compound concentration within the 
proteoliposomes led to a dequenching and hence an increase of the fluorescent signal, 
which could be quantified over time. Verchére et al.119 advanced this approach and 
embedded the two P. aeruginosa efflux pump subunits MexAB and OprM into separate 
groups of liposomes (Fig. 4 G). Those containing the MexAB complex on their surface 
featured a pH dependent fluorescence indicator, whereas those with OprM had RNA 
inside. Ethidium bromide located in the acidic suspension medium surrounding the 
liposomes was taken up by the pump and intercalated with the RNA leading to an 
increase of fluorescence intensity. Further studies with fluorescent derivatives may 
help to find more distinct rules, which can potentially keep antibiotics from efflux. 
 
1.4.2.5 Supported phospholipid bilayers 
 
Moreover, more or less complex supported phospholipid bilayers have been created, 
to mimic  the entire cell envelope120 or the outer membrane121,122. Hsia et al. used outer 
membrane vesicles to include more specific bacterial structures121. The similarity to 
actual bacterial membranes was studied either by surface plasmon resonance (Fig. 4 
H) or dissipation monitoring by a quartz crystal microbalance (QCM-D, Fig. 4 I). 
Although these membrane models might be the closest artificial approximation to the 
actual bacterial envelope, the plain surface, these membranes were built on, will not 
allow to study translocation events properly, but rather membrane interactions with 
different agents (antimicrobial peptides, self-supported uptake, attachment of drug 





1.4.3 In silico assays 
 
1.4.3.1 Molecular dynamics 
 
The predominant technique to assess the permeability of antibiotics is molecular 
dynamics simulations on pure lipid membranes or patches with introduced porins (Fig. 
4 J). Di Meo et al. gave a comprehensive review about simulations on drug partitioning 
and crossing through the lipid membrane including antimicrobial peptides123, while 
Pothula et al. reviewed advances in the field of porin mediated drug transport covering 
OmpF124–126 using -lactams or fluoroquinolones, but also other outer membrane 
proteins of E. coli, such as OmpC127. Several groups studied further channels, e.g. 
OmpG, OmpA of E. coli; FecA, OprP, OprO, OprD, and OccK5 of P. aeruginosa; PorB 
of Neisseria meningitidis, CarO of Acinetobacter baumannii128,129, and CymA130 of 
Klebsiella oxytoca. Simulating translocation processes can be demanding, especially 
when performing all-atom simulations. Hence, simulations usually cover short time 
frames only (nanosecond range) to keep the processing time within an acceptable 
range. This leads to a time scale problem131, since biological processes usually happen 
within ms range. Prospectively, it is possible to reduce the complexity and increase the 
calculated time interval by using coarse grain models, where groups of atoms are 
merged to one ‘grain’. Molecular dynamic simulations of compound permeation are 
usually accompanied with experimental data, predominantly from electrophysiological 
experiments or the aforementioned OMV swelling assay. This indicates that molecular 
dynamics simulations can either be used to develop hypotheses, which can then be 
experimentally confirmed or if experimental data are available first, to explain the 
permeation behaviour of a compound. An additional MD-based application was 
reported using a scoring function, which features physicochemical properties (charge, 
dipole, minimum projection area) of the diffusing molecule, properties of the porin 
(diameter of constriction zone, electrostatic potential, electric field) and their mutual 




1.4.3.2 Machine learning 
 
In addition to molecular dynamics simulations, machine learning techniques deserve 
particular attention, when predicting the overall antibiotic accumulation, but also 
permeation, degradation and efflux. Machine learning is an approach that can take an 
infinite number of variables into account, which are expected to be involved in these 
processes. Random forest analyses (Fig. 4 K) are particularly advantageous machine 
learning applications in fields of research, which depend on empiric data from living 
organisms, since they require a comparably low amount of data for the training, which 
can even be partially incomplete. So it is no surprise that the documented machine 
learning applications related to bacterial bioavailability are random forest 
analyses80,132. Recently, the employment of a neuronal network yielded new promising 
anti-infective compounds, even though not using accumulation data but large data sets 
of MIC133.  
 
Figure 4. Selection of most important techniques to investigate bacterial bioavailability 




Table 3. Selection of assays for studies on bacterial accumulation and related 
processes. 
Assay class Method Advantages Disadvantages Applicable for 
Whole-cell assays Indirect compound 
quantification via 
supernatant[77,100] 
+ low equipment requirements 
+ easy quantification 
- no distinction between molecule 
accumulation, adhesion, partition 






+ highly specific 
+ suitable for automation 
- compound purification 
- sophisticated equipment 
- comparably slow 
Accumulation,  
(permeability) 
-Spectrofluorimetry[82] As in LC–MS, but  
+ less sophisticated equipment 
+ upscalable/automation 






+ accumulation-time course  
+ upscalable/automation  
- only fluorescent compounds 





TOMAS[86] + upscalable 
+ information about efficacy 
+ less sophisticated equipment 
- does not monitor accumulation directly 
- sophisticated biotechnological 
preparation of bacterial strains 
Accumulation, 





+ less sophisticated equipment 
+ covers lots of aspects of 
passive permeation across OM 
(using OMV’s) or specific ones 
(using proteoliposomes) 
- only for known membrane proteins 
- isolation of membrane proteins/OMV’s 
necessary 
- only highly soluble compounds 
- lack of precision 
Permeability 
Electrophysiology Black lipid membrane-
based[87] 
+ translocation of single 
molecules 
+ adjustable to different bacterial 
strains by OMV 
- migration along electric field instead of 
concentration gradient 
- susceptible to disturbances 





on single substances  









independent uptake   
Efflux assay Liposome assembly[94,102] + study of efflux pump function 
+ mimicry of active transport 
mechanisms 
- preparation and loading of 
proteoliposomes 
 
Efflux studies on 







+ most accurate morphology 
+ highly sensitive 
- highly fragile, sensible to impurities 
- only studies of adsorption but no 
Binding studies of 
compounds to 
membrane structures 
In silico Molecular dynamics[97] + detailed elucidation of 
structure–permeation 
relationships 
+ strain and structure specific 
- time consuming 
- requires deep experience 
- complex 




Machine-learning[46] + fast 
+ less sophisticated equipment 
+ relatively straight forward 
+ predictive 






1.5 Known physicochemical properties for good accumulation into Gram-
negative bacteria 
 
Physicochemical optimizations are commonly done on drug candidates, in order to 
enhance their target specific binding or their bioavailability in the patient. For most of 
the anti-infectives the bioavailability within the bacterial organism must be also 
considered. Since most of the established anti-infectives follow passive uptake into 
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Gram-negative bacteria, this section will only consider rules for enhanced passive 
permeation.  
Currently known physicochemical properties for good bacterial bioavailability partially 
differ from those known to yield a good bioavailability in the patient. Here, it is 
recommended to first summarize the criteria to increase the likelihood for good human 
bioavailability reported by Lipinkski et al.134 and Ghose et al.135: 
• < 5 hydrogenbond donors 
• < 10 hydrogenbond acceptors 
• < 500 Da of molecular weight (160 – 480 Da) 
• clogP < 5 (-0.4 – 5.6)  
• molar refractivity (40 – 130) 
• number of atoms (20-70) 
Overall, molecules should be small and have a slightly lipophilic tendency.   
In contrast to this, an average logP of -4 was reported for compounds active in Gram-
negative bacteria indicating that those compounds should be rather hydrophilic. This 
notion was further supported by analysing the clogD at pH 7.479,136 and by looking at 
the polar surface area, which was found to be comparatively high.  
Molecular size was also found to be important for good accumulation in Gram-negative 
bacteria. Often, the limit of 600 Da is stated19,79,137, but this value should not be 
considered as generally applicable for every species or a sharp cut-off, as older 
studies138 and very recent ones show139. It indicates that good accumulating 
compounds in Gram-negative bacteria may be slightly larger than those optimal for 
human bioavailability. Apart from these traditional parameters, so-called “eNTRy”-rules 
have been suggested. Antibiotics with good accumulation in E. coli were found to have 
preferably an primary amine (“N”), a low thee-dimensionality (“T”, globularity < 0.25) 
and a high rigidity (“R”, rotatable bonds < 5) 80,140.   
Pursuing these rules indeed led to the development of novel anti-infectives80,141, 
however their toxicity to mammalian cells remains unknown. Acosta-Gutierrez et al. 
reported a computational tool to predict the permeation into Gram-negative bacteria 
via general porins, where a high partial atomic charge, dipole moment and net charge 
together with a low minimal projection area benefit the predicted permeability35.  
Moreover, positive charges are favourable for good permeation, particularly as a part 
of a zwitterionic structure35,59,142. Their approach takes into account porin-specific 
morphologies, which may become more relevant for drug discovery in future.  Recent 
findings point to the direction that possibly different bacterial strains will have their own 
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specific favoured physicochemical properties for enhanced permeation and 
accumulation132.  
Generally, it is currently known that the following features are likely to enhance Gram-
negative accumulation or activity, respectively: 
• primary amine80,140 
• zwitterionic structure35,59,142 
• Flat molecular shape (globularity 0.25)80,140 
• Rigidity (rotatable bonds 5)80,140 
• slight hydrophilicity (clogP ~ -0.1, clogDpH7.4 ~ -2.8, rel. PSA ~ 42 Å)79,136 
• Molecular weight  ca. 600 Da19,79,137 
It is, however, important to bear in mind that certain features might also enhance the 
toxicity. Primary amines together with aromatic system are known to enhance the QT-
time, potentially leading to a life-threatening arrythmia143. Small, flat rigid molecules 
bear the risk to act as intercalators to DNA144.  
The aforementioned basic guidelines for good antibiotic accumulation may have 
already been indirectly implied by Paul Ehrlich, who established the term of 
“chemotherapy” and “magic bullet”, reasoning that there are certain dyes, which will 
selectively kill pathogenic microorganisms145. The attempt to seek antibiotic 
compounds among dyes is an interesting approach, which indeed led to arsphenamine 
(‘salvarsan’, 1910) and neoarsphenamine (‘neosalvarsan’, 1912), the first 
commercially available antibiotics146,147. It was used for the treatment of gonorrhoea 
caused by Treponema pallidum – a Gram-negative bacterial species. 
Sulfamidochrysoidin (prodrug of sulfanilamide) found by Gerhard Gomagk in 1935, is 
a dye also with activity against E. coli148–150.  
Notably, the aforementioned features: low globularity and high rigidity are typical of 
dyes commonly featuring aromatic systems. The presence of amine groups causes 
negative mesomeric (-M) effects (ammonium groups) at physiological pH, while 
phenolic OH-groups cause positive mesomeric (+M) -effects. If both moieties are 
combined with an aromatic system, bathochromic and hyperchromic shifts are 
achieved at pH 7.4, also leading to a zwitterionic structure. The obtained substance is 
likely to be coloured and meets the most crucial criteria for accumulation in Gram-
negative bacteria at the same time. More timely examples of such compounds are 
fluoroquinolones, tetracyclines and some -lactam antibiotics. 
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1.6 Aim of this Thesis 
 
As was pursued already by Florian Gräf et al.1, the general aim of this dissertation is to 
present possible in vitro solutions to for a better assessment and prediction of antibiotic 
accumulation in Gram-negative bacteria. Although in the past years particular effort 
has been spent on the improvement of probing the accumulation of antibiotics directly 
within bacteria with doubtlessly remarkable achievements (see section 1.4.1 Cell-
based assays), those methods still have disadvantages, making those studies costly, 
sophisticated and time consuming. In contrast to the previous approach, the main 
hypothesis of this dissertation is that the reduction of the model to the most important 
permeation delimiting features will enable for sufficient performance in predicting the 
accumulation in bacterio, while it will simplify and shorten model preparation as well as 
permeability investigation under lower material costs.   
The obtained modelling approaches would then be upscalable and usable by a large 
amount of applicants, ranging from small sparsely-equipped chemistry labs to big 
pharmaceutical companies, engaged in antibiotic research.  
 
Three chapters will be devoted to these aims: 
i) Completion of the functional characterization of the overall membrane 
model 
ii) Polysaccharide gels as membrane model  
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Sufficient bacterial bioavailability is the key for the activity of antibiotics with intracellular 
targets. Especially, overcoming the Gram-negative bacterial cell envelope is not a 
trivial venture. While several in vitro models were developed to easily predict oral 
bioavailability, as for example Caco-2 cell assays, MDCK cell assays or so-called 
parallel artificial membrane permeability assays (PAMPA) employing liposomes 
(phospholipid-based permeation assay, PVPA) or aliphatic materials, such as 
hexadecane, equivalents to measure bacterial bioavailability are missing. Inspired by 
a liposome-based approach by Flaten et al.3,114–116 mimicking the mammalian 
phospholipid membrane, a similar procedure was followed employing liposomes 
partially representing the membrane phospholipid composition of E. coli and P. 
aeruginosa2,117. This mono-layered phospholipid-based permeation model was further 
advanced with the aim to obtain a multi-layered membrane structure representing the 
total Gram-negative cell envelope94. A brief summary of the membrane preparation and 
structure is given in Figure 5.  
 
Figure 5. Overview of the preparative steps to build the total membrane model. Filter 
supports of a 12-well Transwell®-plate are coated with a liposomal suspension to create the 
inner membrane (IM). After liposome fusion, an alginate solution is placed on top and cross-
linked by a CaCl2 solution to create the periplasmic space (PS) compartment. The outer 
membrane (OM) on top of the alginate gel is created by a phospholipid coating for the inner 
leaflet (IL) and subsequent LPS nebulization to form the outer leaflet (OL). 
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Various microscopy techniques were performed, such as (correlative) scanning 
electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) to clarify 
the structure of the created model. While, these could successfully demonstrate an 
even distribution of LPS after its nebulization and the inner membrane layer, the 
asymmetry of the outer membrane and the total four-layered structure (inner 
membrane, periplasmic space, inner- and outer leaflet of outer membrane) could not 
be sufficiently proven.   
Moreover, the validity of the model needed further investigation employing clinically 
established antibiotics, whose way and extent of uptake is widely understood. 
In this chapter, the aforementioned total envelope model is further structurally and 









salt) (POPG), and 1,1′,2,2′-tetra-(9Z-octadecenoyl) cardiolipin (sodium salt) (CL) were 
obtained from Avanti Polar Lipids Inc. (Alabaster, AL, USA), while 
Transwell® filter supports 3460 (0.4 µm pore Ø) were obtained from Corning Inc. 
(Acton, MA, USA). Protanal LF 10/60FT (alginate) was purchased from FMC 
BioPolymer (Ayrshire, UK). Tetracycline-HCl was obtained from chemodex (St. Gallen, 
Switzerland). Rifampicin was obtained from USBiological (Swampscott, MA, USA). and 
pipemidic acid were obtained from LKT Laboratories, Inc. (St. Paul, MN, USA). , 
novobiocin sodium was purchased from Cayman Chemical Company (Ann Arbor, MI, 
USA). Hydrochloric acid and sodiumhydroxide solutions (1 M each) were used from 
Bernd Kraft (Duisburg, Germany). Methanol, Acetonitrile (both HPLC grade), Acetic 
acid (glacial) were obtained from VWR Chemicals (VWR International S.A.S., 
Fontenay-sous-Bois, France). Smooth lipopolysaccharides (LPS; from Escherichia 
coli, 0111:B4) with or without fluorescein isothiocyanate (FITC) label and other 
reagents and chemicals not further specified were sourced from Sigma-Aldrich (St. 
Louis, MO, USA).  
 
2.3 Methods   
 
2.3.1 Preparation of total envelope model 
 
Inner membrane: 
5 mL bacteriomimetic liposomes were prepared from the synthetic phospholipids 134 
mg POPE, 66 mg POPG, 33 mg CL by thin film hydration technique. The blend of 
phospholipids was dissolved inside a 250 mL round bottom flask by 5 mL of a blend of 
chloroform and methanol (3 : 1). The solvents were evaporated by a Rotavapor R-205 
(BÜCHI Labortechnik GmbH, Essen, Germany) at 200 mbar, 80°C, 135 rpm for 30 min 
followed by further pressure reduction to 40 mbar for 1h. The formed lipid film was 
hydrated in 5 mL of PBS (pH 7.4) containing 10 % (v/v) ethanol using the same rotary 
evaporator without reduced air pressure at 70°C, 135 rpm for 1h. The obtained 
liposomal suspension was broken down to small unilamellar vesicles using an 
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ultrasonication bath for 1h (RK 106, Bandeln electronic GmbH & Co. KG, Berlin, 
Germany). Subsequent homogenization of the liposomes happened by 10 fold 
extrusion through an ISOPORETM ATTP membrane filter with 0.8 µm poresize (Merck 
Millipore Ltd, Tullagreen, Carrigtwohill Co., Cork, Ireland) using a Liposofast L-50 
extruder (Avestin Europe GmbH, Mannheim, Germany) at 70 °C.  
Periplasmic space model 
Two different protocols were followed to prepare the periplasmic space model.  
In case of the standard protocol 75 µL/well of a 2 % (w/v) alginate solution were pipetted 
on top of the inner membrane model followed by adding 25 µL/well of a 5 % (w/v) 
calcium chloride solution and resting at room temperature for 1 h.  
In the case of the improved protocol 5 times 100 µL 5 % (w/v) calcium chloride solution 
were nebulized on top of previously pipetted 75 µL/well 2 % (w/v) alginate solution. 
Nebulization was performed with an Aerogen Solo nebulizer (Aerogen Ltd., Galway, 
Ireland) in combination with a customized nebulization chamber. After nebulization, 
membranes rested for 1 h at room temperature. 
 
Outer membrane model 
For the inner leaflet, 37.5 μL of a phospholipid mixture of POPE and POPG (90:10 
weight ratio) were coated on Transwell® filter inserts were coated in two cycles the 
phospholipid composition was chosen according to the composition 151,152 divided by a 
drying step of 4 min at 55 °C using an incubator (Memmert UN75, Memmert GmbH & 
Co, KG; Schwabach, Germany) following each cycle. To prepare the OL, a 0.3 mg/ mL 
LPS solution was then nebulized in five cycles onto the prepared IL structure, using an 
Aerogen Solo nebulizer (Aerogen Ltd., Galway, Ireland) together with an in-house 
developed nebulization chamber (see Supporting Information). A final drying step of 5 
min at 55 °C was then employed. 
 
2.3.2 Confocal laser scanning microscopy of outer membrane model and total 
envelope model 
 
The OM and total envelope models were prepared as described above, employing 
fluorescein isothiocyanate (FITC)-labeled lipopolysaccharides (LPS) to form the outer 
leaflet (OL) and staining the inner leaflet and inner membrane (IL) with laurdan (ratio 
phospholipids to laurdan 400:1 mol/mol). Samples were subsequently cut out of the 
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plastic holder support, attached to a glass slide using medium viscous Baysilone® 
silicone paste (GE Bayer Silicones GmbH & Co. KG, Leverkusen, Germany) as a fixing 
agent, and covered with a coverslip. Imaging was performed at 40x magnification by 
z-stacking using a Zeiss LSM 710 AxioObserver (Carl Zeiss Microscopy GmbH, Jena, 
Germany; λex=405 nm and λem= 457 nm in the case of laurdan and λex= 488nm and 
λem= 564 nm in the case of FITC-labeled LPS).  
 
2.3.3 Stereomicroscopy of total envelope model 
 
Samples were prepared as described above, cut out of the plastic holder support and 
attached to a glass slide using a nitrocellulose solution. Uncovered samples were 
investigated under a Zeiss Discovery-V20 featuring an Axiocam MRC camera and run 
with AxioVision Rel. 4.8.2 software (all by Carl Zeiss AG, Oberkochen, Germany). 
 
2.3.4 X-ray microtomography of total envelope model 
 
The structure of the total envelope was characterized by X-ray microtomography 
employing beamline P05 operated by Helmholtz Zentrum Geesthacht (HZG) at the 
storage ring PETRA III of DESY, Hamburg. Therefore, the total membrane was 
prepared using the standard and the improved protocol (see above) for the PS and 
subsequently fixed and stained by exposing the coated Transwells® for 2 h to a 1% 
(w/v) OsO4 solution. Afterwards, slices of 3 mm width and 12 mm length were cut out 
and placed into a thin plastic tube of 3 mm diameter. Samples were exposed to X-ray 
synchrotron radiation using a photon energy of 12 keV. The tomographic 
reconstructions were performed from 1200 projections equally stepped while turning 
180°. Visual data were processed employing VGSTUDIO MAX software (Volume 
Graphics GmbH, Heidelberg). 
2.3.5 Total envelope model functional characterization  
 
The permeation of two sets of clinically established antibiotics, novobiocin, rifampicin, 
and erythromycin as porin-independent antibiotics and tetracycline as a porin-
dependent control and the gyrase inhibitors ciprofloxacin, norfloxacin, pipemidic acid, 
and nalidixic acid, was determined. Regarding ciprofloxacin and norfloxacin a 1 mg/mL 
stock solution was prepared in 0.1 M hydrochloric acid. 1 mg/mL stock solutions of 
pipemidic acid and nalidixic acid were prepared in 0.1 M sodium hydroxide solution. 
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Novobiocin and tetracycline were directly dissolved in KRB (pH7.4) to obtain a 1 mg/mL 
stock. Erythromycin (1 mg/mL) and rifampicin (100 μg/mL) stock solutions were 
prepared by dissolution in KRB (pH7.4) containing 2% DMSO. All stock solutions were 
diluted to an initial donor concentration of 50 μg/mL using KRB, and the pH was 
adjusted to 7.4. For studies employing tetracycline and nalidixic acid, samples were 
taken after 0, 0.5, 1, 1.5, 2, 2.5 and 4.5 h. In the case of erythromycin and rifampicin. 
an additional time point was taken at 4.5 h. For novobiocin, ciprofloxacin, norfloxacin 
and pipemidic acid, samples were taken after 0, 2, 2.5 and 4.5 h.  
 
2.3.6 LC-MS/MS analysis 
 
An Accela UHPLC system coupled TSQ Quantum Access Max tandem quadrupole 
mass spectrometer (both from Thermo Fisher Scientific, Waltham, MA, USA) was 
employed. The UHPLC device featured a quaternary mixing pump, an online degasser, 
a thermostated autosampler and a column oven containing an accucore RP-MS 
column (150 x 2.1, 2.6 µm, Thermo Fisher Scientific, Waltham, MA, USA). The entire 
system was operated through the standard software XcaliburTM (Thermo Fisher 
Scientific, Waltham, MA, USA).  
For ciprofloxacin, norfloxacin and pipemidic acid an isocratic binary solvent mixture 
was used (A: acetonitrile + 0.1% formic acid; B: ammoniumformate-buffer 10 mM pH3) 
with 18% of A 82% of B. As for novobiocin, tetracycline and erythromycin, a gradient 
run was employed shifting from 18% to 90 % of A and from 82% to 10% of C (water + 
0.1% formic acid) within 2 min. After that A and C were kept constant for another 3 min. 
Due to practical reasons the quantification of erythromycin was performed by 
determining the main compound erythromycin A. Regarding rifampicin, a gradient was 
used starting from 18% of A  and 82% of C and then shifting to 90% of A and 10% of 
C within 3min. After that, the amount of C was lowered to 5% and A was increased to 
95%. This ratio was kept for another minute.  
The detection of the compounds in the MS happened after heated electrospray 
ionization (H-ESI) during positive ion mode using for Sulfamethoxazole single ion 
monitoring (SIM) and for all others selective reaction monitoring (SRM). The detailed 




Table 4. Quantification parameters of employed gyrase inhibitors, erythromycin, 













Erythromycin A 3.06 4000 280 716.3 558.4;158.0;
540.4;522.4 
Rifampicin 3.77 4500 270 823.3 791.5;399.1;
151.0;163.0 
Novobiocin 2.40 5000 260 613.2 189.1;133.1;
396.1;218.1 
Tetracycline 2.46 4000 300 445.1 410.2;154.0;
226.0;241.0 
Ciprofloxacin 2.37 5500 300 332.1 231.0;245.0;
288.1;314.1 
Norfloxacin 2.28 4500 300 320.1 302.2;231.1;
276.2;282.2 
Pipemidic acid 1.69 5500 300 304.1 286.1;217.1;
215.1;189.1 
Nalidixic acid 3.36 5000 300 233.1 131.1;159.1;
187.1;215.1 
 
2.3.7 Statistical analyses 
 
Tests for significance and plotting of permeation data were all carried out using 
GraphPad Prism® 7.04 software (GraphPad Prism software Inc., San Diego, CA, USA). 





2.4 Results and discussion 
 
2.4.1 Structural characterization of outer membrane model 
 
Even though CLSM was performed previously to evaluate, if the IL and OL of the total 
model form an asymmetric combination of layers, results were unsatisfying. In general, 
optical microscopy of such a membrane model is a challenging task, as the LPS are 
hydrophilic and may be dissolved again if sample preparation features hydrophilic 
liquids. Hydrophobic liquids on the other side may dissolve the phospholipid layer 
underneath. To solve this problem, it was hypothesized that a highly viscous and highly 
hydrophobic gel, such as silicon grease (Baysilone®) may be suitable to mount the 
sample for microscopy. In contrast to other highly hydrophobic materials with high 
viscosity, as for example Vaseline, Baysilone is completely translucent.   
By staining the phospholipids with the fluorescent dye lauran prior to filter coating and 
nebulizing FITC-labelled lipopolysaccharides, two fluorescence signals could be 
obtained. The embedding in silicon grease proved indeed to be a suitable means to 
preserve the bilayered structure of this amphiphilic combination of layers (Fig. 6). 
However, light green spots on the lower side indicate, that parts of the 
lipopolysaccharide solution were able to penetrate the phospholipid layer and 
accumulated in the pores of the filter membrane. Nevertheless, the obtained 
micrograph allows for an estimation of the thickness of the outer membrane being 
approximately 10 µm.   
The outer leaflet, which, seemingly seems to not be entirely homogenously distributed, 
appears to have a thickness of up to 3 µm, whereas the significantly thicker leaflet 
reaches partially up to 9 µm. A two layered structure can be observed with FITC-labeled 
LPS located on top of the laurdan stained inner leaflet, composed of phospholipids. 






Figure 6. CLSM micrograph of the outer membrane compartment of the total membrane 
model. FITC-labelled LPS (light green), representative for the outer leaflet lie on top of the 
laurdan-stained phospholipid layer (blue) representing the inner leaflet. A certain quantity of 
the added lipopolysaccharide could penetrate the phospholipid layer and enrich in the 
unstained Transwell® filter membrane.  
 
2.4.2. Structural characterization of total envelope model 
 
In addition, CLSM was applied to elucidate the entire model structure. However, after 
preparation of the sample according to the same protocol, CLSM imaging failed to 
reveal an actual three-layered membrane structure of the model, composed of an IM, 
PS and OM part (Figure 7). This has several reasons. First, it seems that phospholipids 
of the inner leaflet accumulate at specific points of the membrane and form partially 
cloud-like structures leaving other parts uncoated. Notably, those parts with a 
phospholipid top layer have no visible layer underneath pointing to a dramatic decrease 
in laser intensity after passing the top layer. Hence, no emitted light signal could be 




Figure 7. CLSM mircrograph of the total envelope model. IL and IM were stained with 
laurdan. Cloud like structures of the IL at the 700 µm mark are located approximately 100 µm 
over a second layer (IM).  
Further structural studies on the total envelope model employing stereomicroscopy 
(Fig. 8) revealed that it features concentric grooves, when the periplasmic space 
surrogate is prepared by pipetting the crosslinking CaCl2-solution directly on the 
alginate layer.  
Figure 8. Comparison of the surface structures of the entire model obtained with either 
pipetting (A) or nebulizing 5 % (w/v) CaCl2-solution on top of the 2 % (w/v) alginate 
solution. Concentric rings in A indicate an inhomogenous gel formation, whereas nebulization 
led to a more even surface structure. Observed bubbles result from the excision of the models 




As x-ray microtomography demonstrated, these grooves, indeed, lead to an uneven 
distribution of the IL phospholipids within the total envelope model, hence leaving parts 
of the alginate layer uncoated (Fig. 9).  
 
Figure 9. X-ray microtomographic image of the total envelope model. The different grey 
tones are specific for the three layers (inner membrane, IM; periplasmic space, PS; outer 
membrane, OM) of the model. An accumulation of OM phospholipids is visible in the valleys of 
the PS coating. 
In order to improve the distribution of phospholipids and LPS on top of the alginate 
layer the gelatinization technique was therefore altered. The 5% CaCl2-solution (w/v) 
was nebulized instead of pipetted. This method could guarantee that the gelatinization 
process became initiated at every part of the alginate surface at the same time, while 
also assuring an equal amount of CaCl2 to be distributed over the entire alginate layer. 
This procedure led to the disappearance of the concentric grooves (Fig. 8, B) and a 
more distinct separation between inner membrane, periplasmic space and outer 




Figure 10. X-ray microtomographic images of the total envelope model after the calcium 
chloride solution was pipetted (A) and after the calcium chloride solution was nebulized 
on top of the alginate gel (B). Nebulization according to the new protocol thus led to a better 
separation of the three layers as well as the formation of a more even membrane structure. 
 
2.4.3 Functional characterization 
 
Graef et al. designed a membrane model of the entire Gram-negative bacterial cell 
envelope. While he could demonstrate a dependency between PqsD-inhibitor 
permeability across this in vitro model and the potential to inhibit the production of HHQ 
in P. aeruginosa, the direct dependency between in vitro permeation and in bacterio 
accumulation still needed to be proven and structure permeability relationships needed 
to be discussed. We therefore employed a small panel of antibiotics expected to follow 
passive porin-independent or largely porin-dependent permeation (Fig. 11). Figure 11 
B depicts the absolute permeated amounts of the three porin-independent antibiotics 
novobiocin, rifampicin and erythromycin after 2.5 h and 4.5 h and tetracycline as a 
porin-dependent control. The overall permeated amount of these compounds is 
remarkably low. For porin-independent antibiotics, such as novobiocin, rifampicin and 
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erythromycin A, the low permeability is in agreement with their classification as low 
accumulating compounds80. The comparatively low degree of tetracycline permeation 
observed in the total envelope model is expectable, because of its documented 
reliance on porins in order to permeate across the Gram-negative cell envelope153 and 
is additionally validated by a high degree of observed accumulation in porin-competent 
E. coli. Notably, these distinct differences between compound permeabilities only 
emerged at the 4.5 h time point. 
 
Figure 11. Permeability of the porin-independent antibiotics novobiocin, erythromycin 
A, and rifampicin as well as the porin-dependent compound tetracycline across the 
improved total envelope model. Compound characteristics can be seen in (A), with their 
respective permeated amounts after 2.5 h and 4.5 h are shown in (B). Low accumulating, porin-
independent compounds are highlighted in red, while compounds with reported high 
accumulation in bacterio and porin-dependent uptake are highlighted in green.  Values 
represent mean ± SE; n ≥ 12 from three independent experiments. Two-way ANOVA was 
performed with Tukey’s multiple comparisons test, ***P<0.001 
 
Figure 12. Permeation of structurally related gyrase inhibitors in the improved total 
envelope model. Compound structures and key physicochemical parameters are provided in 
(A), while their respective permeated amounts after 2.5 h and 4.5 h are shown in (B). NXD = 
nalidixic acid, PIP = pipemidic acid, NOR = norfloxacin, CIP = ciprofloxacin. Values represent 
mean ± SE; n ≥ 12 from at least three independent experiments. Two-way ANOVA was 
performed with Tukey’s multiple comparisons test, **P<0.01, ***P<0.001, ****P<0.0001 
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Another step toward the establishment of such a model for studies of structure-
permeation relationships was taken by probing the permeability of the structurally 
related gyrase inhibitors ciprofloxacin, norfloxacin, pipemidic acid, and nalidixic acid 
(Fig. 12). Nalidixic acid showed a significantly higher permeation than the other 
compounds after 2.5 h and 4.5 h, likely due to its status as the smallest and least 
hydrophilic molecule154. The permeabilities of ciprofloxacin, norfloxacin, pipemidic acid, 
and nalidixic acid were observed to increase with decreasing molecular weight (Mw), 
pointing to a stronger impact of this parameter than of compound polarity (logDpH7.4, 
Figure 12 A). Another fact contributing to the good permeability of nalidixic acid is 
certainly the increased amount of uncharged microspecies at pH 7.4 (ca. 2%), while 
such a microspecies is virtually absent for the other largely zwitterionic gyrase 
inhibitors155,156. This corroborates the earlier reported inferior permeation of zwitterionic 
ciprofloxacin across a lipid layer in comparison to its neutral species157. This 
permeation behaviour through porin-free membranes is in contrast to porin-expressing 
E. coli, where a positive charge in particular seems necessary to allow for an enhanced 
access to the constriction region of the porins OmpF and OmpC158–160. In spite of the 
absence of those passive diffusion channels and active transporters, the obtained data 
illustrate the value of such a model to exclude, e.g., poorly permeable candidates at a 
rather early stage of drug development or to further optimize the design of novel anti-
infectives toward better permeability. 
2.5 Conclusion 
 
Based on previous work by Graef et al.161, a Transwell®-based model of the entire 
Gram-negative bacterial cell envelope was further improved and characterized. The 
asymmetry of the outer membrane was shown by CLSM, while after optimizing the 
gelation process of the alginate solution, a smooth, three-layered structure resembling 
the outer membrane, periplasmic space and inner membrane could be observed using 
X-ray microtomography. Permeation studies employing already marketed and well-
established antibiotics show that the porin-less model is able to predict the permeability 
of those antibiotics following passive, porin-independent uptake. As in conventional 
bilayered membranes the permeation of zwitterionic compounds was inhibited 
compared to compounds devoid of charge.  
Overall, it must be said that this model has potential to become employed for predicting 
the permeation into Gram-negative strains with downregulated porins or species, 
where porin-mediated transport is less relevant per sé. 
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3. Polysaccharide Gels as Membrane Model 
 
Main Contributors: 
Robert Richter, Mohamed Ashraf M. Kamal, Mariel A. García-Rivera, Jerome Kaspar, 
Maximilian Junk, Walid A. M. Elgaher, Sanjay Kumar Srikakulam, Alexander Gress, 
Anja Beckmann, Alexander Grißmer, Carola Meier, Michael Vielhaber, Olga Kalinina, 
Anna K. H. Hirsch, Rolf W. Hartmann, Mark Brönstrup, Nicole Schneider-Daum, Claus-
Michael Lehr 
 
The contributions were as follows:  
R. Richter  performed all experiments related to model development 
and validation, including support of the random forest-
mediated investigation of structure-permeation 
relationships, developed the printing protocol, 
developed, and assessed structural membrane analysis 
on a plate reader, writing of chapter 
M. A. M. Kamal  supported the experiments as an undergraduate student.  
M. Garcia-Rivera &       performed and conceived bacterial uptake studies,  
M. Brönstrup        LC-MS analysis and revised the manuscript  
W. A. M. Elgaher  synthesized RNAP inhibitors and performed activity   
studies, supervised by.   
R. W. Hartmann       supervision of RNAP synthesis and activity 
& A. K. H. Hirsch      studies  
M. Junk performed the construction and engineering part of the 
customized printer 
J. Kaspar & M. Vielhaber  supervision of printer construction and engineering 
S. K. Srikakulam, A. Gress    carried out random forest analysis  
& O. Kalinina  
A. Beckmann, A. Grißmer       contributed the freeze-fracture experiments and  
& C. Meier         analysed data 
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N. Schneider-Daum        are the initiators of the project and responsible for the   








After the “Golden Age of Antibiotic Discovery” (1930’s to 60’s) the number of novel 
antibiotic classes being introduced into the market has been steadily decreasing162–164, 
while bacterial resistance is continuously increasing165. Especially, the treatment of 
infections caused by Gram-negative bacteria lacks novel classes of anti-infectives, and 
the antibiotic drug pipeline is only poorly filled166. While the limited profitability of 
antibiotic research is one crucial factor for this crisis, the development of novel 
antibiotics is additionally hampered due to intrinsic and acquired resistance 
mechanisms of bacteria167. Since most of the antibiotics for the treatment of Gram-
negative bacteria, such as -lactams, tetracyclines, fluoroquinolones and 
aminoglycosides have to reach intracellular targets, it is obvious that the Gram-
negative bacterial cell envelope is an important hurdle for the efficacy for such 
antibiotics. The elements of this biological barrier (e.g. outer membrane proteins, 
lipopolysaccharides, periplasmic space, -lactamases, cytoplasmic membrane), which 
antibiotics have to overcome on their way to the target, have already been described 
previously11,19,31,158,168–171 and are detailed in chapter 1.1 and 1.2 of this thesis.   
In this chapter, we present a hydrogel-based assay for a relatively simple, quick and 
cost-effective high throughput concept. Among hydrogel forming agents, 
polysaccharides are particularly advantageous, since some of them are already 
regularly employed for analytical and preparative methods, such as size exclusion 
chromatography, dialysis, and gel electrophoresis. Furthermore, their gelation is 
straightforward, the material costs are low, and they are considerably diverse in 
physicochemical as well as structural properties. This allows for the imitation of a wide 
range of different barrier properties.  
By measuring the compound permeability across positively, negatively and uncharged 
polysaccharide-gels, correlations to their accumulation and activity in Gram-negative 
bacteria were investigated. In spite of the simplicity of this approach, especially 
permeability data from 20% (w/v) starch hydrogels showed a surprisingly good 
prediction, qualifying it as an interesting tool for optimizing the transport of anti-infective 
compounds across this important biological barrier and omitting potentially inactive 
compounds at an early stage of antibiotic drug development.  
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3.2 Materials  
 
 
MultiScreen® 96-well Filter plates with 0.4µm PCTE membrane and MultiScreen® 96-
well Transport Receiver Plates were obtained from EMD Millipore Corporation 
(Billerica, Ma, USA). Sodium Alginate (Protanal LF 10/60 FT) was obtained from FMC 
Biopolymer UK Ltd. (Girvan, Ayrshire, UK). Amylopectin (ELIANE 100) and potato 
starch (Partially hydrolysed, Mw>1.500 kDa, amylose content 33%) were donated by 
AVEBE U.A. (Veendam, NE). Agarose SERVA (research grade) and Streptomycin-
SO4 were obtained from SERVA Electrophoresis GmbH (Heidelberg, Germany). 
Ampicillin-Na (CELLPURE®) was obtained from Carl Roth GmbH + Co. KG (Karlsruhe, 
Germany). Aztreonam was obtained from MP Biomedicals, LLC (Illkirch, France). 
Tetracycline-HCl was obtained from chemodex (St. Gallen, Switzerland). Rifampicin 
was obtained from USBiological (Swampscott, MA, USA). Tigecycline and pipemidic 
acid were obtained from LKT Laboratories, Inc. (St. Paul, MN, USA). Imipenem was 
obtained from MOLEKULA® GmbH (Munich, Germany). Amylose, novobiocin sodium 
and sulfamethoxazole were purchased from Cayman Chemical Company (Ann Arbor, 
MI, USA). Phosphate buffered saline (pH 7.4) was prepared from dissolution of 0.02M 
PBS tablets without potassium (Genaxxon Bioscience, Ulm, Germany) in 1 l of Milli-Q 
water. Hydrochloric acid and sodiumhydroxide solutions (1 M each) were used from 
Bernd Kraft (Duisburg, Germany). Methanol, Acetonitrile (both HPLC grade), Acetic 
acid (glacial) were obtained from VWR Chemicals (VWR International S.A.S., 
Fontenay-sous-Bois, France). Methylene blue was obtained from J.T. Baker 
(AvantorTM Performance Materials, Radnor, PA, USA). FluoraldehydeTM (o-
phthaldialdehyde reagent solution) was obtrained from Thermo Fisher Scientific 
(Waltham, MA, USA). Chitosan (high molecular weight), tobramycin, kanamycin 
monosulfate, phosphomycin disodium, erythromycin, ciprofloxacin, chloramphenicol, 
norfloxacin, minocycline hydrochloride, sparfloxacin, fusidic acid sodium, levofloxacin, 
clindamycin hydrochloride, lincomycin hydrochloride, cefuroxime sodium were 




3.3 Methods  
 
3.3.1 Assessment of polysaccharide gels 
 
3.2.1.1 Membrane preparation 
 
Due to differences in the viscoelastic properties of the employed polysaccharide gels, 
concentrations varied between the different polysaccharides. Alginate gels of 5, 10, 15 
and 20 % (w/v) were made by suspending respective amounts of Protanal LF 10/60 FT 
in 30 mL of Milli-Q water. The suspension was kept overnight at a 70 °C water bath to 
allow for complete dissolution. 3 % (w/v) high molecular weight chitosan gel was 
prepared by suspending 300 mg chitosan in 10 mL acetic acid (1% v/v) and letting stir 
overnight until complete dissolution. 0.02M sodiumhydroxide solution was optionally 
given to neutralize the gel (pH7.4). 2.5, 5, 7.5, 10 % (w/v) agarose gels were prepared 
by suspending the respective amount of agarose in 10 mL Milli-Q water and heating 
the suspension in the microwave for 1 min at 600 W. 10, 15, 20, 25, 30, 35 % (w/v) 
Starch gels were prepared by suspending respective amounts of slightly acid degraded 
potato starch in 10 mL of Milli-Q water and boiling the suspension while stirring until a 
clear solution was obtained. The same procedure was performed for 10, 15, 20 and 
25 % (w/v) amylopectin and 30, 40, 50, 60 % amylose. A displacement pipet 
(Transferpettor®, Brand GmbH & CoKG, Wertheim, Germany) was used to coat each 
filter support of the MultiScreen® 96-well filter plate with 40 µL of the respective 
polysaccharide formulation. Gelatinization was supported by keeping the covered and 
coated filter plate overnight at 4°C. 
 
3.3.1.2 Preparation of donor solutions 
 
100 µg/mL donor solutions of rifampicin, novobiocin, tetracycline, clindamycin and 
chloramphenicol were prepared by direct dissolution of the compounds in PBS (pH 
7.4). 100 µg/mL solutions of quinolones were prepared by dissolving 1 mg of compound 
in 1 mL of 0.1 M sodium hydroxide solution, addition of 4 mL of PBS (pH 7.4), 
neutralization by 1 M hydrochloric acid solution and filling up to 10 mL by PBS (pH 7.4). 
 
3.3.1.3 In vitro permeation assay  
 
Assays were performed using the gel coated donor wells of a 96-well filter plate in 
combination with a 96-well receiver plate. For equilibration, 200 µL of PBS (pH 7.4) 
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were given to each well of the filter plate and 300 µL to the respective acceptor wells 
of the receiver plate followed by assembling filter and receiver plate and incubating the 
obtained transport system for 30 min with PBS (pH 7.4) at 37°C while being placed on 
an orbital shaker (IKA®- Werke GmbH and Co KG, Staufen, Germany) at 180 rpm. 
After incubation, PBS was removed from both plates. 230 µL pre-warmed antibiotic 
donor solution (37°C) was given into the respective donor wells, while 30 µL were 
immediately removed and diluted 1:10. The absorbance of the obtained dilutions was 
measured in an additional receiver plate using a Tecan Infinite® 200 PRO (Tecan 
Trading AG, Maennedorf, Switzerland) plate reader. 300 µL of fresh PBS (pH 7.4) were 
given into the respective acceptor wells of the receiver plate and their absorbance was 
also measured. After that, filter and acceptor plate were reassembled, the donor wells 
sealed with adhesive foil, covered with a lid, and incubated (37°C, 180 rpm). After 10, 
20, 30, 45, 60, 90, 120, 150, 180, 210, 240 min the transport system was temporarily 
disassembled to measure the absorbance in the acceptor wells of the receiver plate. 
An adjusted protocol was followed for substances with insufficient λmax. In these cases, 
220 µL of donor solution were given in each donor well. 20 µL were immediately 
removed and diluted 1:10. At all aforementioned time points, samples of 40 µL were 
drawn from acceptor wells and diluted 1:5 for subsequent liquid chromatography 
coupled mass spectrometry (LC–MS). In case of tobramycin and kanamycin, samples 
of 20 µL were drawn and a previously reported quick fluorimetric approach was 
followed (o-phthalaldehyde assay).  The removed volume was replaced using fresh 
PBS (pH 7.4). Permeated amounts of each compound were calculated in reference to 
calibration curves, which were prepared from the applied donor solution. Details 
regarding the absorbance and LC–MS measurements can be seen below. 
 
3.3.1.4 Calculation of the apparent permeability coefficient (Papp) 
 
A linear regression was performed on a cumulative permeation-time curve, at which 
the accumulated drug amount has not yet exceeded 10% and no lag time occurred. 
The obtained slope was divided by the surface area of the filter to obtain the compound 






Where c0 is the initial donor concentration (µg/cm3), A is the surface area of the filter 




3.3.1.5 Printing of membranes 
 
For an automated coating of the membranes a custom 3D-printer was designed based 
on modular aluminium construction profiles with controls based on a Duet 2 32 Bit 3D-
printer controller running a customized version of RepRapFirmware 2.02. The printer 
features igus® SHT spindle drive linear axes fitted with igus® MOT-AN-S-060-020-056-
L-A-AAAA motors (both igus® GmbH, Cologne, Germany) for x/y/z motion with a 
resolution of 5 µm ± 5 % and theoretical microstepped resolution of up to 0.625 µm. 
Extrusion of the starch solution is accomplished by a 10 mL Hamilton® SaltLine 
reagent syringe (model 1010 TLL-SAL, Hamilton® Company, Reno, NV, USA) driven 
by a Nanotec L4118S1404-M6X1 Hybrid linear actuator (Nanotec Electronic GmbH & 
Co. KG, Feldkirchen, Germany; full-step volume resolution of the driven syringe 0.837 
µL per step). The syringe was kept at 80 °C by a VWR® refrigerated circulating bath 
with a digital temperature controller (model 1166D, VWR® International, LLC., Radnor, 
PA, USA). The hot water supply for the syringe consisted of a Masterflex L/S® easy-
load® peristaltic pump (Cole-Parmer, Vernon Hills, IL, USA) adjusted to speed 1 and 
OMNILAB silicone tubing (5 x 2 x 9 mm, OMNILAB-LABORZENTRUM GmbH & Co. 
KG, Bremen, Germany) as well as PhthalateFree® PVC Pump Tubes (3.18 mm ID, 
Gilson® Company Inc., Lewis Center, OH, USA). A trimmed Sterican® needle for 
special indications (G 14 x 3 1/8” / Ø 2.10 x 80 mm, B. Braun Melsungen AG, 
Melsungen, Germany) was used as a nozzle.   
For investigating the accuracy and precision of the printing in comparison to pipetting, 
the volumes 20, 30, 40, 50, 60, 70 and 80 µL were extruded into an empty 1.5 mL 
Eppendorf tube® of known weight. The weight of the extruded volume was measured 
and converted into the corresponding volume after determining the density of water at 
the current experimental conditions. Same procedure was done using a positive 
displacement pipette “Transferpettor”, Digital, DE-M (Brand GmbH + Co.KG, 
Wertheim, Germany).   
The g-code used to print the starch solution into the donor wells can be found in 
supporting information 3.  
 
3.3.1.6 Absorbance scan of membranes and quantitative structural comparisons 
 
As a quick check for batch homogeneity and evenness, 20 % (w/v) starch solutions 
were stained with 100 µg/mL methylene blue before coating the filter membrane. The 
coated filter plates were afterwards assembled to their support plate and their 
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absorbance was scanned without lid using the Tecan Infinite® 200 PRO plate reader, 
with Tecan i-control, 1.10.4.0 software (Tecan Trading AG, Maennedorf, Switzerland). 
The membrane scan was done at 666 nm (bandwidth 9 nm), using 15 x 15 reads/well 
with 25 flashes/read, no settle time and a border of 850 nm. As plate type, ‘Millipore 
MultiScreen 96 Flat Bottom Transparent Polysterol’ was selected. The obtained 
absorbance values per well were aligned in x and y direction and subsequently plotted 
as a 3D surface diagram using Microsoft® Office Excel 2016 (Version 16.0, Microsoft® 
Corp., Redmond, WA, USA).          
Gel deposition was calculated by computing the average absorbance per membrane 
using the previously obtained data and calculating the overall mean. For the intra well 
variability, the mean of the standard deviations of absorbance for each membrane was 
calculated. Regarding the intra batch variability, the absorbance standard deviation of 
each membrane was averaged for each batch, before calculating the mean of the 
obtained values, while as for the inter batch variability, the standard deviation of the 
mean absorbance from each batch of membranes was calculated. Obtained data 




In order to assess and compare the thickness of printed and pipetted membranes. 20 
% starch solutions were stained with 100 µg/mL methylene blue before coating the filter 
membrane. Following membrane coating the donor wells were cut off using a hot blade 
and embedded in Tissue-TEK® O.C.T.TM cryo embedding compound (Sakura Finetek 
Europe B.V., Alphen aan den Rijn, NE) and frozen to -20°C. Afterwards, vertical 
sections were performed until reaching the centre of the well. Cryosectioning was done 
using a SLEE ECO Cryostat MEV (SLEE medical GmbH, Mainz, Germany). The 
remaining half of the well was mounted onto a glass slide and investigated under a 
Zeiss Discovery-V20 stereo microscope featuring an Axiocam 512 colour camera and 
processed with AxioVision Rel. 4.8.2 software (all by Carl Zeiss AG, Oberkochen, 
Germany). Obtained data are from at least 3 batches consisting of at least triplicates. 
 
3.3.1.8 Transmission electron microscopy (TEM) of freeze-fracture replicas 
 
For the analysis of the polysaccharide gels in TEM, starch hydrogels were prepared by 
dissolving modified potato starch in water (final concentrations were 10% or 20% or 
40% (w/v)). Hydrogels of 10% agarose, 20% amylopectin and 30% amylose (w/v) were 
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prepared in water too. The solutions were dropped onto glass cover slips and kept in 
the refrigerator for solidification. 24 hours later, small slices of the hardened hydrogel 
were cut with a scalpel. The slices were incubated with phosphate-buffered saline 
(PBS) for 30 min at 37°C and 5% CO2. Thereafter, small pieces of the hydrogel slices 
were mounted in between a sandwich of copper carriers (one flat-bottom, one with 
depression) and plunge-frozen into a nitrogen-cooled liquid ethane-propane mixture 
using the Leica plunge freezer EM CPC (Leica Microsystems, Wetzlar, Germany). 
For analysis of hydrogels made of 20% alginate, 3% chitosan (acidic) or 3% chitosan 
(neutralized) (each prepared in water), small drops of 24h-old solution were pipetted 
into a well of a 96 well plate and incubated with PBS at RT. 30 min later, the PBS was 
taken off and small drops of the hydrogels were plunge-frozen in a sandwich of two 
flat-bottom copper carriers.  
Afterwards, the sandwich carriers were mounted in a cryo-preparation box onto a 
nitrogen-cooled finger replica table and transferred with an EM VCT shuttle into the EM 
BAF060 freeze-fracture and etching device (all devices from Leica Microsystems). 
Freeze-fracturing was performed at -162°C and 1x10-7 mbar by chipping off the upper 
copper carrier. Fractured samples were etched for 5 min at -100°C. The etched faces 
were rotary shadowed with a 1.5 nm platinum-carbon coat applied at a 60°C angle, 
followed by a 20 nm carbon coat applied at 90°. The replicas were stabilized on a gold 
index grid using 0.5% Lexan polycarbonate plastic dissolved in dichloroethane (DCE). 
After evaporation the DCE by incubating the sample-replica-Lexan-grid at -20°C for 16 
h, the samples were thawed at room temperature and the carriers were removed. The 
grids were floated on 70% H2SO4 for 3 h to dissolve the starch from the replicas. After 
removal of the starch, the grids were floated for 1 h on double-distilled water. The grids 
were dried on filter sheets and a 20nm carbon coat was applied at 90° for further 
stabilization. After removal of the Lexan film by incubation in hot DCE, analysis was 
performed using a FEI Technai G2 transmission electron microscope (FEI, Thermo-
Fisher Scientific, Munich, Germany) at 100 kV, equipped with a digital 8-bit camera. 
The negative contrast was reversed for image interpretation, so that the heavy metal 
appears white and the shadow appears black.  
 
3.3.1.9 Validation of permeation assay 
 
Membrane preparation, creation of donor solutions and permeation assays were 
performed as mentioned under ‘Assessment of polysaccharide gels’, however, with few 
changes. The amount of time points was reduced to 10, 20, 30, 45, 60 and 90 min and 
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donor solutions contained an equimolar concentration of 200 µM for each tested 
compound. Since the most valid results were obtained at a time interval, at which not 
all compounds showed a linear permeation behaviour, the area under the curve 
(AUC10-30 min) was calculated instead of the Papp. Therefore, GraphPad Prism® 
7.04 software (GraphPad Prism software Inc., San Diego, CA, USA) was used. 
 
3.3.1.10. Application examples  
Permeation studies were performed as under ‘Assessment of polysaccharide gels’, 
however with few changes. The amount of time points was reduced to 10, 20, 30, 45, 
60 and 90 min. For the assessment of RNAP inhibitors, donor solutions contained an 
equimolar concentration of 100 µM, while for the assessment of Fluoroquinolone-





For compound quantification, an Accela UHPLC system coupled TSQ Quantum 
Access Max tandem quadrupole mass spectrometer (both from Thermo Fisher 
Scientific, Waltham, MA, USA) was used. The UHPLC device featured a quaternary 
mixing pump, an online degasser, a thermostated autosampler and a column oven. 
The entire system was operated via the standard software XcaliburTM (Thermo Fisher 
Scientific, Waltham, MA, USA). Streptomycin samples were quantified using a 
Synchronis HILIC column (50 x 2.1 mm, 1.7 µm, Thermo Fisher Scientific, Waltham, 
MA, USA) column. For all other compounds, an Accucore RP-MS column (150 x 2.1, 
2.6 µm, Thermo Fisher Scientific, Waltham, MA, USA) was employed. The 
chromatographic analysis was performed with a binary solvent mixture using optionally 
acetonitrile + 0.1 % formic acid (A), MilliQ-Water + 0.1 % formic acid (B), Methanol + 
0.1 % formic acid (C) or ammonium formate buffer (10 mM, pH 3, D). Ampicillin and 
sulfamethoxazole were analysed using an isocratic run with 60 % B and 40 % C or 40 
% A and 60 % B, respectively. All other compounds followed a gradient run. As for 
clindamycin and lincomycin, the initial value of 18 % A and 72 % D was shifted to 30 
% A and 70 % D within 2 min and then kept constant for another 2 min. As for 
tobramycin and streptomycin, 95 % A and 5 % B was shifted after 2 min to 5 % A and 
95 % B within 1.5 min. This ratio was kept for 3.5 min. Vancomycin samples were run 
for the first minute with 5 % A and 95 % B before shifting within 1 minute to 95 % A and 
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5 % B and keeping the values for 3 min. Erythromycin was run starting with an 
immediate shift from 18 % A and 82 % D to 90 % A and 10 % D within 2 min. The latter 
ratio was kept constant for 3 min. Fusidic acid started with 35 % B and 65 % C. After 2 
min, the values changed to 5 % B and 95 % C within 1 min. After that, these values 
were kept constant for 4 min. The detection of the compounds in the MS happened 
after heated electrospray ionization (H-ESI) during positive ion mode using for 
Sulfamethoxazole single ion monitoring (SIM) and for all others selective reaction 
monitoring (SRM). Employed LC–MS parameters are listed in Table 5.
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Table 5. LC-MS parameters used for in vitro assay. 




































174 5500 300 310 25 0 10 








95 4500 300 300 35 0 10 
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102 4000 280 280 40 0 2 
Fusidic acid 300 25 6.34 539.400 479.4 18 124 5000 260 280 45 0 25 










95 5000 300 300 15 0 5 
Sulfamethoxa- 
zole 





At selected time points, the antibiotic concentration in the receiver plates was 
quantified without lid by absorbance using a Tecan Infinite® 200 PRO plate reader, 
run by Tecan i-control, 1.10.4.0 software (Tecan Trading AG, Maennedorf, 
Switzerland). Antibiotics and the wavelengths used for their quantification are shown 
in Table 6. The measurement was done with a bandwidth of 9 nm, 25 flashes per read 
and without settle time. As plate model ‘Millipore MultiScreen 96 Flat Bottom 
Transparent Polysterol’ was selected. 




Nalidixic acid 330 
Norfloxacin 324 



















20 µL samples of tobramycin and kanamycin were given into corresponding wells of a 
96-well microplate (Polystyrene, F-bottom, non-binding; Greiner Bio-One GmbH, 
Frickenhausen, Germany). 200 µL of FluoraldehydeTM were given to each well and 
after 5 min the fluorescence was measured (λex=360 nm, λem=470 nm) using a Tecan 
Infinite® 200 PRO plate reader and Tecan i-control, 1.10.4.0 software (both Tecan 
Trading AG, Maennedorf, Switzerland). 
 
3.3.2 In bacterio control assay 
 
3.3.2.1 Bacterial uptake 
 
5 mL of Luria Bertani broth (LB broth) were inoculated with E. coli K-12 MG1655 and 
incubated overnight at 37 °C and 150 rpm. 2 x 60 mL of fresh LB broth were inoculated 
with 1 mL of overnight culture (starting OD600 ≈0.1) and incubated at 37 °C, 150 rpm 
till OD600 = 0.7 was reached. The bacterial culture was centrifuged in 50 mL Falcon 
tubes (9 min, 4500xg, 20°C), the supernatant was removed and following resuspension 
of the pellet in 5 mL NaPi-MgCl2 buffer (50 mM sodium phosphate (NaPi) + 5 mM 
MgCl2 adjusted to pH=7.0, sterile filtrated) the suspension was centrifuged under the 
same conditions. Again, the supernatant was discarded, and the pellet resuspended 
in enough warm NaPi buffer to reach OD600= 5.0. The obtained suspension was kept 
at 37°C for 5 min. 100 µL of bacterial suspension were given per well into a 
MultiScreenHTS DV filter plate (transparent, pore size 0.45 µm, Merck Millipore, 
Tullagreen, IRL) wetted with 2 µL NaPi buffer. At time points 0, 2, 5, 10, 20, 30, 42, 47, 
50, 52 min, 25 µL of the respective antibiotic solution was added and mixed in the 
corresponding wells to give a final volume of 125 µL and a concentration of 200 µM. 
The filter plate was shaken at 350 rpm and 37°C in a ThermoMixer® C (Eppendorf 
GmbH, Hamburg, Germany) during antibiotic addition. For the 0 min time point, 25 µL 
of antibiotic solution were added right before filtration. The Incubation was stopped at 
the respective timepoint by fast removal of the supernatant with a vacuum manifold 
(~15 s) and washing the cells twice with 100 µL of ice-cold NaPi buffer done by a Bravo 
Automated Liquid-Handling Platform (Agilent Technologies, Santa Clara, CA, USA) 
and filtered again. The filter plate was pressed against absorbent paper to remove the 
remaining liquid after every filtration. The filter plate was put on top of a 350 µL conical 
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bottom receiver plate (clear poplypropylene, Greiner Bio-One GmbH, Frickenhausen, 
Germany) and the pellets were resuspended in 100 µL of ice-cold methanol-water 
blend (8:2). After that, the suspension was incubated for 30 min at room temperature 
(RT) and 400 rpm while being sealed with Parafilm® (Bemis Company Inc., Neenah, 
WI, USA) and closed with a lid. Following the incubation step the filter plate was 
centrifuged at 2250 x g for 5 min and the filtrate collected in the receiver plate. The cell 
debris was further lysed by adding 100 µL of ice-cold acetonitrile to the filtrate and 
mixing before it was incubated for 30 min at RT and 400 rpm. Further centrifugation at 
2250 x g for 15 min and collection of filtrate was then followed by evaporation using a 
centrifugal vacuum concentrator at 20 °C coupled to a cold trap at -50°C (both from 
Labconco Corporation, Kansas, MO, USA). The dry remnants were reconstituted in 
100 µL of a methanol-acetonitrile blend containing 0.1 % formic acid and 10 ng/mL 
caffeine as internal standard, with the exception of streptomycin and tobramycin, which 
were reconstituted in 100 µL of water containing 0.1 % formic acid and 10 ng/mL 
caffeine. Samples were subsequently measured with an LC-MS method specific for 
each compound. To determine the unspecific binding of the tested compounds, 100 
µL of NaPi buffer were added to a blank filter plate and incubated for 5 min at 37°C. 25 
µL of compound from stock solutions were added and mixed as mentioned before. The 
plate was incubated until the last time point in the assay and, from then on, treated like 
the bacteria-containing plate. Standard curves were obtained by measuring predefined 
concentrations of antibiotic. The integrated peak area where then plotted over antibiotic 
concentration in µM, and a linear regression curve was performed by least squares. 
The amount of antibiotic in bacterial samples was determined based on the regression 
curve and the sample volume (100 µL). To calculate the effective accumulated amount 
obtained, the amount of corresponding compound in nmol from unspecific binding was 
subtracted from all data obtained from bacterial incubation.  
To correct for a four times higher drug concentration compared to the protocol by M. Richter 







Samples were quantified by an Agilent 1290 UHPLC (Agilent Technologies, Santa 
Clara, CA, USA) coupled to an AB Sciex QTrap 6500 ESI-QQQ (AB Sciex Germany 
GmbH, Darmstadt, Germany) mass spectrometer. For chromatographic separation a 
ZORBAX Eclipse Plus C18 (2.1x5.0, 1.8 µm, Agilent Technologies, Santa Clara, CA, 
USA) column was employed. A linear gradient was applied using water + 0.1 % formic 
acid (A) and acetonitrile + 0.1 % formic acid (B), in which the initial amount 99 % A 
shifted to 1 % A over a period of 5 min and at a flow rate of 0.7 mL/min. 
Chromatographic separation of tobramycin samples was carried out in a Shodex 
HILICpak VC-50 2D column (20x150mm, 5µm, Showa Denko America Inc., NY, USA). 
A linear gradient was applied using water + 1.5 % ammonia (A) + and acetonitrile 0.1 
% formic acid, starting at 70 % A and reaching 90 % A over a period of 5 min and at a 











Table 7. LC-MS parameters used for in bacterio assay. 
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3.3.3 Permeability-activity investigations 
 
Based on the obtained in vitro permeation data the apparent permeability coefficient 
(Papp) was calculated. These data were plotted against MICs for E. coli, P. aeruginosa, 
A. baumannii, K. pneumoniae, C. jejuni, Salmonella spp., and N. gonorrhoeae obtained 
from the database of the European Committee on Antimicrobial Susceptibility Testing 
(EUCAST). Since this data base usually provides distributions of reported MICs, those 
values were selected, which had the highest number of reports.  
 
3.3.4 Statistical analyses 
 
Tests for significance and plotting of permeation data were all carried out using 
GraphPad Prism® 7.04 software (GraphPad Prism software Inc., San Diego, CA, USA). 
3.3.5 Random forest analysis 
 
The random forest model was created using randomforest library172 in R (v. 3.6.1; R 
Core Team, R Foundatation for Statistical Computing; 2017, Vienna, Austria). The 
input data (AUC10-30 min, net charge, molecular weight, minimum projection area, 
relative abundance of unsaturated bonds, number of rotatable bonds, number of 
hydrogen bond acceptors, number of hydrogen bond donors, globularity, clogDpH7.4) 
was initially processed and stored as a table. We used leave-one-out cross validation 
to develop this model with the hyperparameters ntree of 100, mtry of 2 and maxnodes 
of 8. Where ntree is the number of decision trees we allow this model to grow, mtry is 
the number of variables randomly sampled at each split or tree node and maxnodes is 
the maximum number of terminal nodes every tree in the forest can have. The depth 
of the tree can be controlled using the maxnodes hyperparameter. In the process of 
model optimization clogDpH7.4 and number of rotatable bonds were removed as input 
parameters to enhance robustness and avoid overprediction. To ensure reproducibility, 
the seed value ‘6’ was randomly selected. All physicochemical parameters were 
calculated by MOE (relative abundance of unsaturated bonds, number of rotatable 
bonds, H bond acceptors and donors, globularity) and chemicalize.com (net charge, 
molecular weight, minimum projection area, clogDpH7.4). The code used for the analysis 




3.4 Results and discussion 
 
3.4.1 Selection of filter plate 
 
To enhance the throughput of compounds, the 12-well Transwell®-system was 
exchanged for a 96-well filter plate (MPC4TR10) by Merck Millipore. The different 
specifications are depicted in Table 8.  
Table 8. Feature comparison of the previously used 12-well corning plate and the 
favoured 96-well filter plate. 
 Corning




Number of wells 12 96 









Pore size [µm] 0.4[a] 0.32 – 0.4[b] 
Porosity [pores/cm²] 4*106[a] 108[b] 
Cost per Transport 
system in total [€] 
82.00[c] 73.62[c] 
Cost per well [€] 6.83 0.77 
[a] data kindly provided by Corning Inc., Corning, NY, USA   
[b] data kindly provided by Merck KGaA, Darmstadt, Germany  
[c] price calculated from: https://www.sigmaaldrich.com/catalog/product/sigma/cls3460?lang= 
de&region=DE (last access: 18.06.2020, 7:00 pm)   
[d] price calculated from: https://www.merckmillipore.com/DE/de/product/96-well-Collection-
Plate,MM_NF-MATRNPS50 and https://www.merckmillipore.com/DE/de/product/MultiScreen-
Permeability-Filter-Plate-0.4m-non-sterile,MM_NF-MPC4NTR10?ReferrerURL=https%3A%2F%2Fww 






Moreover, the surface properties of both filter membranes were investigated by SEM 
(Fig. 13). Notably, the filter membrane of the Merck Millipore filter plate is rougher and 
contains more pores than the Transwell®-filter membrane. Rough surfaces, can be of 
advantage, especially for coating processes, since they normally show enhanced 
adherence to the coated biomaterial173.  
Figure 13. Comparison of the surface structure of Corning® Costar 3460 Transwell® (A) 
and MPC4NTR10 Multiscreen Permeability (B) filter supports. Transwell®-filter supports 
have a much smoother surface structure than those attached to MPC4NTR10 filter plates, 
which may be due to different protocols in the track-etching procedure to create the membrane 
pores. 
3.4.2 Selection of hydrogel 
Based on these considerations, the four polysaccharides alginate, chitosan, slightly 
acid degraded potato starch and agarose were selected. Hydrogels obtained from 
these polysaccharides were coated onto 96-well filter plates using different mass 
concentrations followed by permeation studies of four representative antibiotics on 
these coatings. Out of these substances, ciprofloxacin (CIP) and tetracycline (TET) are 
known to be high accumulating compounds in the Gram-negative model bacterium E. 
coli MG1655, whereas rifampicin (RIF) and novobiocin (NOV) belong to low 
accumulating compounds80.  
Since the filter supports of the chosen MPC4NTR10 microtiter plate can be also 
considered as a permeation barrier, it is first necessary to investigate the permeation 




Figure 14. Permeation-time course of CIP, TET, RIF and NOV obtained from uncoated 
MPC4NTR10 filter supports. RIF and NOV permeate slightly faster through the uncoated 
filter membrane than CIP and TET. As expected, the overall permeability decreased 
dramatically after the starch coating. Graphs represent mean permeated amounts ± SD. N=9, 
from 3 independent experiments.  
In contrast to a hypothesized faster permeation of the smaller molecules ciprofloxacin 
and tetracycline, rifampicin and novobiocin proved to be faster permeating. Perhaps, 
this phenomenon can be explained by the mediocre hydrophilicity of the membrane 
material174, allowing the passage slightly hydrophobic rather than hydrophilic 
compounds. The low permeability of CIP can be also partially caused by its stacking 
behaviour in solution, which can reduce the accessibility to the membrane pores157. As 
the overall permeation of the four compounds was comparably quick – the compound 
accumulation exceeded sink conditions already after 20 min –, insufficient time points 
were available for the calculation of the apparent permeability coefficient (Papp). In 
contrast to the plain filter support, the compound permeation was sufficiently 
decelerated by all hydrogel coatings and Papp-values could be obtained. Interestingly, 
almost all gel formulations showed separating tendencies between the high and low 
accumulating representatives, with 20 % (w/v) starch gel performing the best (Fig. 15 
A). Charge, as present in alginate and chitosan (Fig. 15 B, C) did not seem to play a 
crucial role. In case of chitosan, deprotonation of the amine groups at neutral pH did 




Figure 15. Papp of CIP, TET, RIF and NOV obtained from different polysaccharide gel 
formulations. The membrane permeability was studied using different formulations of starch 
(A), agarose (B), chitosan (C), alginate (D) as well as of its subcomponents amylopectin (E) 
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and amylose (F). The tendency of discriminating high accumulating from low accumulating 
antibiotics is particularly given at 20 % (v/w) starch formulations. At low concentrations the 
polysaccharide network will not dense enough to allow for differences in permeation, whereas 
too high concentrations of the tested polysaccharides lead to a too dense network and to 
viscoelastic properties, which are non-favourable for a sufficient coating of the filter support. 
Graphs represent mean ± SD. N=9-12, from 3-4 independent experiments. A two-way ANOVA 
was performed with Tukey’s multiple comparisons test. *P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001 
Freeze fracture images suggest that in comparison to starch the network structures 
might be too wide (e.g. for chitosan, Fig. 16 A-B) or too narrow (e.g. for alginate, Fig. 
16 C) to make a difference. Agarose as a further uncharged polymer, forms a rather 
wide and regularly meshed hydrogel network with larger pores (>100nm, Fig. 16 D), 
obviously too large to discriminate the permeability of small antibiotic molecules. 
Additional permeation studies on the two starch components amylose and amylopectin 
(Fig. 16 E, F) demonstrate that the discrimination between CIP and TET on the one 
hand, and NOV and RIF on the other hand is more pronounced by the branched 
polysaccharide amylopectin, but still not as effective as a blend of both.   
 
 
Figure 16. TEM of replicas from various freeze-fractured, etched and replicated vitrified 
gel samples. A: Chitosan (3 % (w/v) pH 3); B: chitosan (3 % (w/v) pH 7.4); C: alginate 20 % 
(w/v); D: agarose 10% (w/v); E: amylopectin 20 % (w/v); F: amylose 30 % (w/v). Where 
possible, hydrogel formulations of 20 % (w/v) were observed to allow for best comparison to 
20 % (w/v) starch gel. In all other cases those concentrations where selected, which are closest 
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to 20% (w/v). The chitosan network, regardless if at low or neutral pH appears to be 
comparatively loose. Alginate, which allowed for higher working concentrations, shows an 
extremely dense gel network that delimits molecular permeation and adequate membrane 
coating. In contrast, the gel network of agarose appears too wide at concentrations suitable 
for membrane coating. The same holds true for amylopectin, whereas the polysaccharide 
strands of amylose also seems again too dense to enable for selective delimitation of antibiotic 
permeation. All micrographs were taken at 98,000x magn. Colours were inverted. Scale bars 
represent 100 nm. 
The latter, according to our findings, leads to slightly denser polysaccharide networks 
of mixed and homogeneously distributed pore sizes (comp. Fig. 16 E, F to Fig. GHZ 
B, E), which may explain the good discriminating performance of 20 % starch gels. 
Moreover, the rare case of volume expansion in course of amylose gelation175 
contributes to the formation of a leak tight gel barrier on top of the filter support after 
deposition, whereas contraction usually causes leakage and affects reproducibility. 
Lower starch concentrations as well as higher concentrations may again lead to 
suboptimal network densities (Fig. 17 A, D and C, F).  
 
Figure 17. Free fracture TEM images of 10 % (A, D), 20 % (B, E) and 40 % (w/v) starch (C, 
F). The mesh width decreases with increasing concentration of starch. Scale bars represent 
100 nm. Moreover, the mesh size distribution becomes more and more homogenous the higher 
the starch concentration is. 
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 The additional investigation of the high accumulating chloramphenicol (CHL) and the 
low accumulating clindamycin (CLI) on the 20% starch formulation also leads to an 
accurate separation by their Papp (Fig. 18). This is noteworthy considering that CLI and 
TET are of similar molecular weight (444.44 Da vs. 424.98 Da). It moreover indicates 
that additional factors other than solely molecular weight must be considered to explain 





Figure 18. Permeation velocity in vitro and accumulation in bacterio80 of a small set of 
high and low accumulating antibiotics. Permeation coefficients of high accumulating CIP, 
TET and CHL as well as low accumulating RIF, NOV and CLI qualitatively match in bacterio 
compound accumulation. N = 9-11 from 3-4 independent experiments. One-way ANOVA was 
performed with Tukey’s multiple comparisons test. *P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001  
Since the absorbance maxima of clindamycin are too low to be used for the 
quantification on the plate reader, liquid chromatography-coupled tandem mass 
spectrometry (LC–MS/MS) was performed. Here, one might ask if both quantification 
methods are comparable. To answer this issue, tetracycline was selected and 
transport studies on the 20% starch hydrogel model were performed using both, 
absorption spectroscopy and LC–MS/MS for quantification. As shown in Figure 19, the 
obtained permeability coefficients differ insignificantly from each other, suggesting that 
both quantification methods are comparable. However, it is worth mentioning that the 
standard deviation of the apparent Permeability coefficient is higher, when obtained 
from LC–MS/MS analysis. This agrees with practical considerations: LC–MS/MS 
requires more preparative steps until the measurement is performed, namely sample 
drawing, volume replacement and sample dilution. While the direct absorbance 
readout from the acceptor plate omits all these steps and hence potential sources of 
error. Due to the comparatively long time of liquid chromatography-based analyses. 
There is a longer time span between sample drawing and sample measurement, which 
can be particularly problematic for substances that undergo oxidation or hydrolysis in 
the meantime. Consequently, direct spectroscopic methods should be favoured for the 




Figure 19. Comparison of apparent permeability coefficients (Papp) of 
Tetracycline obtained from LC–MS/MS and from absorption spectroscopy. The 
Papp obtained from plate reader-based absorption spectroscopy does not significantly 
differ from the Papp obtained from LC–MS/MS. However, the spectroscopic method 
appeared to be more precise. Values represent mean ± SD. n = 9 from 3 independent 
experiments. Mann-Whitney-U-test was performed. n. s. = not significant. 
Moreover, it was investigated if a combination of phospholipid coating and a starch gel 
could have synergistic effects on permeation. Therefore the 20% (w/v) starch 
formulation was coated on phospholipid membranes, as prepared for the inner 
membrane compartment of the total envelope model. Two different concentrations of 
liposomal suspensions were employed to study the impact of the thickness of the 
phospholipid layer. As depicted in Figure 20, the addition of phospholipids favours the 
permeation of small uncharged molecules, such as chloramphenicol, whereas the 
permeation of slightly larger and zwitterionic molecules, such as ciprofloxacin and 
tetracycline are hampered. At the same time, the introduction of an additional layer 
considerably affects the reproducibility of the model, as indicated by the increase of 
standard deviation. The introduction of higher amounts of phospholipids into the 
membrane system may also affect the spectrophotometric quantification, especially 
when measuring the absorbance at 300 nm and lower, loosened phospholipids can 
form small aggregates in the basolateral compartment and increase the absorbance, 
which explains the unexpected increase of chloramphenicol permeability under the 
additional phospholipid layer. On the other hand, the significant difference between 
high and low accumulating compounds, as previously achieved by plain 20% (w/v) 
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starch gel, becomes lost in this hydrogel-phospholipid combination. Only at the lower 
phospholipid concentration, the membrane model shows again a tendency towards 
favourable permeation properties. However, here, it seems that again the starch gel 
dictates compound permeability, while the impact of the phospholipid layer becomes 
subtle. Compared to the accumulation in bacterio (Fig. 18), the pattern of permeabilities 
of the selected panel still appear best, when omitting an additional phospholipid 
coating. 
 
Figure 20. Permeability of four antibiotics across two different gel-phospholipid 
coatings.  As previously shown, Papp-values obtained from 20% (w/v) starch gel for in bacterio 
high-accumulating ciprofloxacin, chloramphenicol and tetracycline are significantly higher than 
Papp-values for low accumulating antibiotics such as novobiocin. When combined with 
phospholipid coatings of different liposomal suspensions (lipos.) the permeability dramatically 
changes. The higher the phospholipid content the less distinct the difference between Papp-
values of high and low accumulating drugs and the higher their standard deviations. 
Chloramphenicol the permeation of chloramphenicol seems favoured, whereas the permeation 




3.4.3 Automation of hydrogel preparation 
 
For better investigation of structure-permeation relationships on a wider antibiotic 
panel, we established a printing method for a more reproducible and standardized 
model production. Therefore, a customized modular and multifunctional bioprinter was 
constructed (Fig. 21) featuring a heated Hamilton® syringe as a print head.  
 
Figure 21. Customized bioprinter. The bioprinter consists of three movable axes (a, 
b, c), which allows for three-dimensional printing. It features an additional vertical axis 
(d) which extrudes the liquid hydrogel into wells of a 96-well filter plate (e). A Hamilton® 
syringe (f) serving as a reservoir and nozzle for the polysaccharide formulation, can be 
heated by a thermostat (g) combined with a peristaltic pump (h) to keep the formulation 





The customized bioprinter works according to so-called g-code commands. A list of 
commands used in this work is given in Table 9. 
Table 9. List of g-code commands relevant for the development of an automated coating 
protocol.  
Command range meaning 
G90 - Use absolute coordination system for all following moves in x, y, 
or z-direction 
G91 - moves printed head relative to current position in x, y, or z-direction 
for all following moves 
G0 - Move print head consecutively in x, y and z direction  
G1 - Interpolate movement of the print head in x, y and z direction 
G2 - Move print head clockwise in a circle  
G3 - Move print head counter clockwise in a circle 
G4 - Pause printing 
X >0.1 Movement of print head along x axis in mm 
Y >0.1 Movement print head along y axis in mm 
Z >0.1 Move print head along z axis in mm 
T 0 Activate tool (syringe extruder) 
E >0.005 Extrude (controls piston of the syringe) in mm 
I >0.1 Defines the location of the centre of the circle, around which the 
print head moves in mm 
J >0.1 Defines radius of the circular movement of the print head in mm 
F 0-1000 Defines speed of print head movement 
M42 - Addresses Peltier element 
P P0, P60 P0: activates heating of Peltier elements      
P60: activates cooling of Peltier elements 
S 0-255 Regulates heating or cooling rate respectively, S1 and S255 cause 
maximum heating or cooling performance, S0 switches off Peltier 
element 
 
Before employing the printer for gel coating, several functions were briefly investigated. 
To find the right working range of the extruder, the required movement of the syringe 
piston (l) can be calculated, when extruding 40 µL (= 40 mm³) of a liquid. This can be 
easily done by assuming the inner space of the syringe to be a perfect cylinder. The 
equation to calculate the cylinder volume is: 
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 With Vcylinder= 40 mm3 and the inner radius of the syringe rinner syringe= 7.3 mm we obtain 
the value of 0.239 mm. This represents the ideal piston range for extruding 40 µL of 
liquid. Different amounts of water were printed, which were smaller and larger than 40 
µL. The actual extruded volumes were compared to corresponding pipetted and 
nominal volumes. Figure 22 demonstrates that printed water volumes very closely 
match the corresponding nominal volumes indicating a good accuracy, whereas 
pipetted water seems to be systematically below. Both extrusion methods, however, 
show a good linear correlation (R²printed = 0.9955 vs. R²pipetted = 0.9991). (R²printed 
=0.9997, when excluding 80 µL.)  
 
Figure 22. Comparison of several printed and pipetted water volumes. Extruding water 
by using the customized printer led to more accurate results within the range of 5 to 70 µL 
compared to pipetted water. A systematic error occurs when using a positive displacement 
pipet. Within 5 to 70 µL the standard deviation of both techniques remains low, whereas the 
standard deviation of printed volumes seems even lower. Points represent mean volume ± SD 
of n = 6, from 2 individual experiments. 
By looking at the standard deviation within the range of 10-70 µL, printing resulted in 
slightly lower standard deviations compared to pipetting.   
The establishment of a printing protocol eligible for a reproducible and complete 





of the needle from the filter membrane, the movement pattern and the distance 
between the wells is crucial.   
Further small explorative studies led to a final code, which is partially displayed in 
Figure 23. Notably, the selected piston range of two times 0.128 mm (Fig. 23 d,e) would 
in the ideal case extrude 42.85 µl instead of 40.00 µL. This seemingly higher nominal 
volume was chosen to compensate for the slightly negative error at these volume 
ranges as previously observed (Fig. 22, blue line). 
 
Figure 23. Excerpt of the g-code used to coat 96-well filter plates. a) Calibration step 
before the actual gel printing: the needle moves to the letter “A” engraved on the 96-well filter 
plate (a). In relative position to this letter all wells are then printed. The needle moves as close 
as possible to the wall of the starting well (b) and stops ca. 0.5 mm over the filter membrane 
(c). From there, the needle performs a slow circular movement while extruding the nominal 
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volume of 20 µL (d). Afterwards, the needle does the same movement with faster velocity while 
extruding another 20 µL (e). To assure complete covering of the filter membrane, the needle 
moves three more times (f), followed by moving to the centre of the well (g) before lifting (h) 
and moving to the next well (i). 
With the refined g-code an entire 96-well filter plate could be adequately coated with a 
20 % (w/v) starch gel.  
For the structural investigation of the obtained starch coatings, a new spectroscopy-
based method was developed. Hydrogels usually suffer from dramatic morphological 
changes in course of their gelatinization and exposure to an environment with low 
humidity, making comparative microscopic studies difficult. Furthermore, the 
preparation for microscopy can cause modifications or damage to the hydrogel 
samples, for example while cutting out the coated filter or while attaching a cover slip 
on top. Investigating the gel morphology directly out of the respective filter well without 
sample preparation is therefore a desirable approach.   
A possible solution would be the absorbance read out on single coated filters using the 
“multiple reads per well” function of a plate reader. In principle fluorescence can be 
used as well. However, the fluorescence read out has a couple of disadvantages, as 
for example the work under light protection,  quenching effects leading to non-linear 
thickness-signal correlations, which holds true especially for thicker membranes and a 
low number of reads per well leading only to a poorly resolved view on the membrane 
topology.  
In contrast, absorbance scans can be performed with up to 177 reads in a filled circle 
pattern. Gelatinized hydrogels are usually turbid. Their turbidity can be measured at 
UV-wavelengths wavelengths from 300 to 350 nm. However, as the spectroscopy at 
low wavelengths is prone to become disturbed by impurities of the gel, the filter 
membrane or the plastic scaffold, the gel can be stained with dyes having an 
absorbance maximum at higher wavelengths. Methylene blue with absorbance 
maxima at 606 and 666 nm (Fig. 24) is one example and was employed in this 




Figure 24. Absorbance spectra of water and methylene blue. While at lower wavelengths 
also the filter plate itself absorbs, absorbance maxima at 606 nm and 666 nm seem particularly 
suitable for a specific detection of methylene blue-stained gel coatings. 
Applying these basic considerations for the characterization of printed and pipetted 
20% (w/v) starch gels indeed allowed for a comparative structural analysis of both 
techniques. In our studies, printed membranes generally had a higher average 
absorbance per well than manually pipetted membranes (Fig. 25 A, B; Fig. 26 A) 
indicating an increased thickness. Moreover, the starch distribution of printed coatings 
was more homogenous, both within and between the produced batches (Fig. 26 B-D) 
In addition, the formation of a meniscus was less prominent after printing (Fig. 25, 27 
A, B).   
 
Figure 25. Topological comparison of pipetted (A) and printed starch (B) 
membrane models. The printed starch coating is thicker and has a less pronounced 
meniscus. Absorbance reads of 177 positions/ well were plotted as a three-
dimensional plotting style.  
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Figure 26. Quantitative absorbance comparisons of pipetted and printed coatings. 
Varying absorbance allows for characterizations regarding the gel deposition per well (A), 
membrane evenness per well (B), fluctuations of gel deposition within a batches (C) as well as 
fluctuations of gel deposition between batches (D). Printed membranes show slightly increased 
deposition rates as well as a slightly enhanced coating homogeneity per well, batch and 
between batches. Bars represent mean ± SD. n9 from at least three batches. AU = 
absorbance units 
 
Figure 27. Stereomicrographs of pipetted (A) and printed (B) 20 % (w/v) starch coatings. 
Pipetted starch gels are more irregular in shape and their deposition is lower. Membranes were 
stained for better contrast with methylene blue. Pictures are representative for at least 9 
samples from at least 3 batches each.   
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In order to evaluate the functionality of the printed membrane model, the permeation 
of the previously employed panel of CIP, TET, RIF and NOV on printed starch 
membranes was studied and compared to the results to manually prepared (Fig. 28) 
membranes. While the permeability pattern of the four selected antibiotics was 
essentially the same, permeation of tetracycline through the printed starch membrane 
was decreased, reflecting that printed coatings were slightly thicker than pipetted ones. 
The data obtained with printed coatings were, however, in even better agreement to in 
bacterio data, indicating a less strong accumulation of tetracycline compared to 
ciprofloxacin80. The standard deviation of the obtained permeability coefficients did not 
noticeably change when the starch gel was printed suggesting that the main causes of 
errors do not happen during the coating process.  
Figure 28. Functional comparison of manually pipetted and printed starch membrane 
models. Permeability coefficients (A) as well as the permeation-time courses (B, C) of two 
high (green) and two low accumulating drugs (red) do not reveal obvious differences. The 
permeation velocity – represented by the Papp-values – slightly decreased for all four 
compounds on printed membranes, with some stronger decrease for tetracycline. The 
decrease can be explained by the increased thickness of printed starch layers. Values 
represent mean ± SD. n=12 from 3 independent experiments. Two-way ANOVA with Tukey’s 
multiple comparisons test was performed. *P<0.05, **P<0.01, ****P<0.0001. 
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3.4.4 Validation of starch gel 
 
After automation of the membrane coating process, we selected 27 antibiotics and 
generated in vitro membrane permeability data to validate the model (Fig. 29, Tab. 10).  
 
Figure 29. Permeation-time course of 27 antibiotics across the starch-based in vitro 






Table 10. Mean permeated amounts and standard error (SE) of the 27 tested antibiotics. 
 
  
Time point [min] 
Ciprofloxacin Nalidixic acid Novobiocin Chloramphenicol 
Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n 
10 1.01 0.14 16 1.24 0.11 12 0.49 0.06 16 1.13 0.14 16 
20 1.75 0.20 16 1.96 0.13 16 0.76 0.05 16 1.98 0.16 16 
30 2.54 0.28 16 2.59 0.13 16 1.06 0.07 16 2.56 0.17 16 
45 3.61 0.38 16 3.57 0.16 16 1.50 0.09 16 3.50 0.19 16 
60 4.43 0.44 16 4.37 0.14 16 1.92 0.09 16 4.28 0.19 16 
90 5.85 0.55 16 5.71 0.15 16 2.70 0.09 16 5.81 0.19 16 
Time point [min] 
Streptomycin Tobramycin Sulfamethoxazole Norfloxacin 
Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n 
10 0.28 0.14 12 0.18 0.04 12 0.34 0.09 16 0.92 0.11 16 
20 0.27 0.13 12 0.36 0.04 12 0.94 0.16 16 1.64 0.16 16 
30 0.70 0.18 12 0.61 0.05 12 1.43 0.19 16 2.07 0.13 16 
45 1.34 0.30 12 1.04 0.07 12 2.36 0.28 16 2.81 0.15 16 
60 1.72 0.32 12 1.52 0.11 12 3.96 0.10 16 3.64 0.22 16 
90 3.06 0.37 12 2.34 0.14 12 5.64 0.10 16 4.79 0.18 16 
Time point [min] 
Cefuroxime Imipenem Amidochelocardin Sorangicin A 
Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n 
10 0.96 0.16 16 0.87 0.11 16 0.66 0.12 12 0.44 0.07 12 
20 1.50 0.20 16 1.64 0.17 16 1.09 0.09 12 0.72 0.08 12 
30 2.03 0.21 16 2.22 0.17 16 1.56 0.10 12 1.00 0.10 12 
45 2.62 0.20 16 3.13 0.21 16 2.10 0.06 12 1.49 0.11 12 
60 3.41 0.19 16 3.76 0.24 16 2.54 0.05 12 1.92 0.12 12 
90 4.46 0.23 16 5.04 0.33 16 3.58 0.05 12 2.84 0.13 12 
Time point [min] 
Tetracycline Tigecycline Lincomycin Clindamycin 
Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n 
10 0.68 0.06 16 0.47 0.08 16 0.23 0.05 12 0.49 0.13 16 
20 1.18 0.08 16 0.90 0.13 16 0.70 0.11 12 1.10 0.19 16 
30 1.78 0.12 16 1.36 0.19 16 1.41 0.26 12 1.42 0.15 16 
45 2.46 0.15 16 1.96 0.19 16 2.01 0.14 12 2.05 0.16 16 
60 3.07 0.16 16 2.54 0.21 16 2.87 0.16 12 2.94 0.25 16 
90 3.90 0.18 16 3.48 0.20 16 3.99 0.12 12 4.26 0.28 16 
Time point [min] 
Pipemidic acid Rifampicin Vancomycin Aztreonam 
Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n 
10 0.89 0.11 16 0.35 0.07 16 0.07 0.02 16 1.16 0.17 16 
20 1.51 0.12 16 0.70 0.11 16 0.21 0.03 16 1.80 0.18 16 
30 2.06 0.14 16 1.10 0.11 16 0.50 0.08 16 2.29 0.21 16 
45 2.92 0.16 16 1.68 0.12 16 0.76 0.09 16 3.10 0.21 16 
60 3.68 0.17 16 2.22 0.13 16 1.14 0.11 16 3.70 0.22 16 
90 4.81 0.16 16 3.16 0.14 16 1.87 0.11 16 4.92 0.23 16 
Time point [min] 
Fusidic acid Ampicillin Erythromycin Levofloxacin 
Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n 
10 0.04 0.01 12 0.60 0.10 16 0.07 0.02 16 0.18 0.07 12 
20 0.09 0.01 12 1.58 0.24 16 0.16 0.03 16 0.47 0.10 12 
30 0.18 0.02 12 2.46 0.36 16 0.30 0.06 16 0.85 0.12 12 
45 0.28 0.03 12 3.44 0.47 16 0.56 0.10 16 1.47 0.14 12 
60 0.49 0.05 12 4.13 0.54 16 0.97 0.17 16 2.11 0.16 12 
90 0.90 0.09 11 5.55 0.56 16 1.91 0.60 16 3.13 0.16 12 
Time point [min] 




SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n Mean 
[nmol] 
SEM [nmol] n 
10 0.06 0.04 12 0.03 0.01 12 0.32 0.04 12 
20 0.17 0.08 12 0.14 0.03 12 0.56 0.04 12 
30 0.46 0.09 12 0.31 0.05 12 0.79 0.04 12 
45 1.04 0.11 12 0.56 0.06 12 1.10 0.04 12 
60 1.73 0.10 12 0.87 0.08 12 1.44 0.04 12 
90 2.83 0.09 12 1.39 0.09 12 1.97 0.05 12 
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Among those, the in vitro data of 10 compounds were compared to their already 
reported in bacterio permeation into wild type E. coli strain MG1655 using the 10 
minutes time point80. As depicted in Figure 30 A, high (green area) and low (red area) 
accumulating compounds according to the in bacterio assay could be analogously 
identified by the starch-based in vitro assay after the same amount of time. It is worth 
mentioning that ampicillin (AMP), which reportedly lacks good accumulation in 
bacterio, shows rather high permeability in vitro. Bearing in mind that -lactams bind 
to their target covalently and may undergo -lactamase mediated hydrolysis, the 
quantification of those compounds by mass spectrometric methods leads to an 
underestimation of their accumulation in bacterio as already discussed previously80. 
Ampicillin fulfils all postulated “eNTRy” rules176 and recently published results of an 
outer membrane vesicle based permeation assay support the assumption of an 
elevated accumulation of ampicillin102. Since there is evidence that ampicillin achieves 
a high accumulation at its target site in the periplasm, the previous classification of 
ampicillin as a low accumulating antibiotic80 should perhaps be reconsidered.   
 
Figure 30. In vitro – in bacterio quadrant analysis. Permeated amounts obtained from the 
in vitro starch model qualitatively suit the reported accumulation in bacterio (A). The in bacterio 
as well as the in vitro assay show a separation into high (green quadrant) and low accumulating 
(red quadrant) antibiotics. Matching results were also found for an additional selection of 
antibiotics (B). Points represent mean permeated amounts ± SE, nin vitro 12 from at least 3 
independent experiments. nin bacterio=4 from 2 biological replicates. [a] reported accumulated 





To further validate our starch-based membrane model, in vitro permeation data of 
additional antibiotics were compared to those obtained from an alternative in bacterio 
control assay95 (Fig. 30 B), which allows for time-resolved permeation studies. Like 
before, an accurate match was found between high accumulating compounds in 
bacterio and fast permeating compounds in vitro already after 10 min. The same held 
true for low accumulating or slow permeating compounds, respectively. TET, CIP, CLI 
and NOV served as comparability check between reported and generated in bacterio 
data. The comparability was confirmed, because a clear separation between high 
accumulating TET and CIP, and low accumulating CLI and NOV, resp., was obtained 
with either assay. By having a look at the permeation-time curves of the in bacterio 
control assay (Fig. 31 A) one can easily notice the division into a low accumulating 
section (streptomycin (STR), tobramycin (TOB), clindamycin (CLI), lincomycin (LIN), 
sulfamethoxazole (SUL), tigecycline (TIG) and NOV) and a small high accumulating 
section (CIP, TET and nalidixic acid (NXD)). As for the starch-based in vitro model an 
accurate discrimination of the antibiotic panel can be seen within the time interval of 
10-30 min (Fig. 31 B). By looking more specifically at the quinolones, nalidixic acid and 
ciprofloxacin reach a high level of accumulation in bacterio, even though NXD 
accumulates more slowly (Fig. 31 A). The comparably high accumulation of NXD 
stands in contrast to results obtained from molecular dynamics simulations performed 
on OmpF and vesicle swelling assays102. Furthermore, it lacks an ionisable nitrogen 
and consequently disagrees with the proposed “eNTRy” rules. However, previous 
permeation studies on a multi-layered lipid in vitro model suggest an extensive 
permeation of nalidixic acid across the LPS and phospholipid layers of the cell 
envelope of E. coli94. The fact that a negatively charged substance highly accumulates 
in rather unspecific in vitro models as well as in living E. coli demonstrates that less 
specific exclusion effects can be already sufficient for adequate predictions.   
TIG showed a poor initial in bacterio accumulation and in vitro permeability. Its 9-t-
(butylglycylamido)-moiety, seems to sterically delimit the access via OmpC and 
OmpF177 in bacterio and also impedes the permeation through the starch network in 
vitro. Additionally, TIG is known for its side chain-mediated decreased efflux178, which 
explains its steadily increasing accumulated amount in course of time without 
fluctuation in bacterio. Another class that turned out to be low accumulating is the 
aminoglycosides. A low accumulation of TOB and STR can be also observed in our in 
vitro model, which is probably due to hydrogen bond formation with the hydroxyl-
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groups of the glucose units of starch. The same effect may occur with LPS, while 
aminoglycosides permeate across the outer membrane in course of ‘self-promoted 
uptake11. Clindamycin and lincomycin, which both feature a carbohydrate structure, 
may suffer from the same mechanism of retention like aminoglycosides. The 
comparably low accumulation of SUL despite its low molecular weight in bacterio is 
remarkable. Probably, the absence of charge at pH 7.4 delimits the permeation through 
porins. At the same time, SUL is rather polar and has a V-shaped structure, which - 
similarly to aminoglycosides and lincosamides - may inhibit the permeation through 
LPS and phospholipids. The structural feature may also play an important role during 
the permeation across starch gel causing an obvious lag time in the beginning. Lag 
times in the beginning of the experiment were also noticed for other compounds, such 





Figure 31. In bacterio accumulation- (A) and in vitro permeation-time course (B) of 10 
antibiotics. Although the accumulation within the bacterium is a multifactorial process, 
similarities can be found in the permeation across the starch-based in vitro model. High 
accumulating CIP and NXD also clearly permeate remarkably well. Also tetracycline shows a 
comparably good permeation within the time interval of 10-30 min, which holds also true for its 
in bacterio accumulation within the same time interval. nin bacterio = 4 from 2 independent 
experiments. nin vitro= 12-16 from 3-4 independent experiments. Error values are not displayed 
for reasons of clarity. 
Another important aspect is precision. As can be seen in Figure 32 A-E, the overall 
scatter is relatively high, whereas within one single experiment it is low. Moreover, high 
accumulating compounds tend to have a higher scatter than low accumulating 
compounds, which is most likely because of the manual pausing of the permeation 
study before the quantification of permeated amounts. As the permeated amount of 
high accumulating compounds increases faster, little deviations in time points can 
cause higher deviations in the concentration-time courses. Prospectively, an 
automation of the transport study will allow to improve on this aspect, especially when 
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investigating the permeation of large antibiotic panels. Moreover, as starch gels 
undergo the process of retrogradation179, it is also important to precisely control the 
time intervals between the production and the use of the hydrogels for the permeation 
study to ensure optimal reproducibility. 
Figure 32. Permeation-time course of chloramphenicol and novobiocin from 4 
experiments. The scatter within one experiment (A, B, C or D) is less pronounced than 





3.4.5 Structure-permeability relationships 
 
Since a non-linear phase of permeation behaviour occurs for some compounds at the 
time interval with most validity (10-30 min), the area under the curve (AUC10-30 min) was 
calculated (see appendix 7.1 “List of employed antibiotics and their physicochemical 
properties”) and used instead of Papp for investigations of structure-permeability 
relationships. Besides, a threshold value was introduced, which classifies substances 
with an AUC10-30min < 21 nmol*min as low permeating and all other molecules as high 
accumulating (Figure 33). This threshold value leads to an accurate classification of all 
previously compounds discussed in the previous chapter. Furthermore, it also 
classifies amidochelocardin as a high accumulating and sorangicin A as a low 
accumulating drug, which is in agreement with their previously reported MICs180,181. 
In agreement with previous findings in bacterio79,182, molecular weight (Mw) determines 
the permeability of compounds through the 20% starch gel model. A decrease in 
permeation can be observed, when plotting the molecular weight of our panel of 
antibiotics against their AUC10-30 min (Figure 33 A) with an apparent cut-off of at ca. 500 
Da. This value is lower than the widely assumed cut-off for general porins of 
Enterobacteriaceae (600 Da)19,137,183. However, focusing only at this descriptor is 
misleading since confounding factors will also contribute. A value clearly below 600 Da 
might support the capability of the model to predict antibiotic accumulation. 
Accumulation is – apart from uptake – also a function of efflux. Studies conducted by 
Astra Zeneca indicate that especially those compounds with Mw between 450 Da and 
600 Da undergo efflux in E. coli and P. aeruginosa136. This condition might have 
contributed to the good match between in vitro permeation and in bacterio 
accumulation.  
Another distinct dependency was found between minimum projection area and drug 
permeation (Figure 33 B).  This value being a hybrid parameter for molecular weight 
and three-dimensionality may be particularly helpful in drug development, since it 
implies that a potentially low accumulation due to high molecular weight can be 
compensated by reducing the spatial molecular expansion. Similar conclusions were 
drawn already recently139. By looking at the dependency between permeation and 
globularity a correlation can also be observed, even though it is less strong, if 
compared to the previous parameters (Figure 33 C).  
As for rigidity, unlike previously reported80 no clear correlation could be found between 
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AUC10-30 min and number of rotatable bonds (Figure 33 D). However, as we selected a 
panel which is quite diverse in molecular size, it seems necessary to use a relative 
parameter, which compensates for the molecular size to investigate the permeation-
rigidity dependency. By the introduction of the relative amount of unsaturated bonds 
instead, we could indeed demonstrate a correlation between molecular rigidity and 
AUC10-30 min (Figure 33 E) indicating that more rigid molecules permeate better. In 
contrast, no clear tendency was found among compounds with amine groups: only 2 
compounds with a primary amine showed high accumulation, whereas 9 of the high 
accumulating drugs did not feature any primary amine and 7 compounds with a general 
amine (primary, secondary or ternary) highly accumulated, whereas 12 compounds 
featuring an amine accumulated low (Figure 33 F). The low number of molecules with 
a primary amine (5) within our panel, however, does not allow for conclusions on their 
impact.    
Rather impressively for a non-charged membrane, molecular net charge appears to 
affect permeation. A permeation optimum was reached at a net charge close to zero 
(Figure 33 G). This phenomenon may be explainable due to ion-dipole interactions of 
permeating molecules to the hydroxyl groups of the polysaccharide network. In this 
regard, it is important to mention that most of the well permeating drugs in vitro are 
zwitterions at pH 7.4 (8 out of 11), whereas the majority of low accumulating antibiotics 
are not (3 out of 14).  The preferred permeation of zwitterionic compounds was also 
reported for the porin OmpF59, where ion-ion interactions determine the 
translocation111.  
We also observed that similar to earlier studies79 the number of hydrogen bond donors 
and acceptors had impact on antibiotic permeation in vitro (Figure 33 H, I). In both 
cases a low number was associated to better permeation.  
Notably, clogDpH7.4 as parameter for hydrophilicity or lipophilicity, also seemed to 
influence drug permeation, since molecules with clogDpH7.4-values between 0 and -5 
permeated best (Figure 33 J). This also suits previously assumptions about an 





Figure 33. Correlations between drug permeation and selected physicochemical 
parameters. From 27 antibiotics, the AUC10-30 min as representative parameter for permeation 
is plotted against (A) molecular weight, (B) minimum projection area, (C) globularity, (D) 
number of hydrogen bond donors and (E) acceptors, (F) net charge, (G) type of amine group, 
(H) number of rotatable bonds, (I) relative abundance of unsaturated bonds, (J) clogDpH7.4. The 
dashed line represents the set AUC10-30min threshold of 21 nmol*min. 
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3.4.6 Random forest analysis 
 
To assess the impact of the chosen physicochemical parameters on the performance 
of the in vitro assay, a random forest regression model (RF) was trained employing 
these physicochemical properties and their AUC10-30 min. Generally, the RF was trained 
with 26 out of 27 tested compounds, whereas the AUC10-30 min of the 27th compound 
was predicted to be high or low accumulating. This was done in 27 cycles, each time 
predicting the AUC10-30 min of another 27th compound after training the model with the 
remaining 26 substances. For the impact of the 10 physicochemical parameters on the 
prediction, we systematically left one parameter out of the RF and compared the 
increase of prediction error (%lncMSE). In this way, the first random forest regression 
confirmed 7 factors (molecular weight, minimum projection area, rigidity, number of 
hydrogen bond donors and acceptors, globularity, charge) to be critical (data not 
shown), for which the process was repeated. With this run, we generated a ranking of 
the importance of the parameters for the prediction (Table 11), where parameters 
representing molecular size and rigidity had the highest impact. When applying the 
threshold of 21 nmol*min  for high and low accumulating compounds on the predicted 
accumulation by RF we achieved an accuracy of 88.89 % compared to the in vitro 
model and 81.25 % compared to those compounds that were tested in bacterio (Table 
12). The absence of clogDpH7.4 as important value is surprising but is perhaps due to 
the low population of antibiotics used to train the RF-model. Nonetheless, we found RF 
model in large agreement with our in vitro and in bacterio results. 




# Hydrogenbond donors 3.26 
Net charge 5.19 
# Hydrogenbond acceptors 5.80 
Relative abundance of 
unsaturated bonds 
16.23 
Molecular weight 27.99 




Table 12. Comparison of AUCs obtained from random forest analysis, in vitro 
permeation studies and in bacterio accumulation studies. Green cells indicate high 
accumulating, red cells indicate low accumulating drugs. 
 
Class Compound 
AUC10-30 min RF 
[nmol*min] 
AUC10-30 min 
 in vitro 
[nmol*min] 
In bacterio  
compound 
classification 
Aminocoumarins Novobiocin 16.400 15.350  
Aminoglycosides 
Kanamycin A 9.200 3.124  
Streptomycin 8.459 7.620  
Tobramycin 8.291 7.620  
Amphenicols Chloramphenicol 27.916 38.270  
Ansamycins Rifampicin 9.355 14.200  
-lactams 
Ampicillin 27.698 31.090  
Aztreonam 21.308 35.300  
Cefuroxim 25.824 29.990  
Imipenem 26.439 31.820  
Glycopeptides Vancomycin 14.115 4.941  
Lincosamides 
Clindamycin 11.517 20.510  
Lincomyin 20.904 15.180  
Macrolides 
Erythromycin A 10.142 3.474  
Sorangicin A 11.272 14.350  
Pyridopyrimidins Pipemidic acid 30.816 29.790  
Quinolones 
Ciprofloxacin 30.384 35.230  
Levofloxacin 27.883 9.819  
Nalidixic acid 23.400 38.720  
Norfloxacin 31.652 31.310  
Sparfloxacin 20.523 11.100  
Steroids Fusidic acid 13.733 2.038  
Sulfonamides Sulfamethoxazole 29.628 18.230  
Tetracyclines 
Minocycline 14.635 4.309  
Tetracycline 19.968 24.090  
Tigecycline 13.215 18.120  
Tetracycl., atyp. Amidochelocardin 25.271 21.96  




3.4.7 Examples of Application 
 
Having demonstrated obvious associations between in vitro permeation and in bacterio 
accumulation, different sets of compounds were tested on the hydrogel model and 
compared to reported data.  
First, we selected three in-house small-molecule inhibitors of RNA-polymerase with 
potent activity against Gram-positive bacteria185 but limited activity on Gram-negative 
species (Table 13). By inspecting the ratio of target inhibition (IC50) and antibacterial 
activity (MIC95) against an E. coli TolC strain, it is obvious that for compound 3 this 
value is below 0.16 indicating a bad access of the compound to its target. This is in 
agreement with its extraordinarily low permeation in our in vitro model (Fig. 34). In 
contrast, the IC50/MIC95 ratio for compounds 1 and 2 was comparatively high and for 
compound 2 even more than twice as high as for compound 1. This difference could 
be reflected by permeability data of our model. In general, it can be noticed that the 
permeability of all three compounds was found to be low despite of their molecular 
weight, which is less than of the fast permeating tetracycline. This, however, is 
plausible considering the absence of a positive charge necessary for the formation of 
a zwitterion and the neutralization of the net charge. Moreover, the lipophilicity of these 
compounds is rather high (clogDpH7.4>2). The particularly slow permeation of 
compound 3 is understandable, since it is the largest, most lipophilic, and most globular 
compound of all three RNA polymerase inhibitors. The overall low permeability of these 
compounds is in agreement with their MIC95 values and could explain the weak activity 

































# HBD Glob. 
1 
 
14 33 0.42 0.37 ± 0.03 51.12 437.3 0,45 5 -1 3 0,013 
2 
 
22 23 0.96 0.34 ± 0.06 39.07 425.3 0,43 6 -1 3 0,011 
3 
 
8 >50 <0.16 0.20 ± 0.08 60.86 562.4 0,48 8 -1 4 0,050 
 
 
Figure 34. Assessment of the permeability of three RNA polymerase inhibitors. The 
comparison to high accumulating CIP and low accumulating NOV indicates that these three 
substances likely belong to low accumulating drugs, whereas 3 probably accumulates 
particularly low. n=9-12 from 3 independent experiments. One-way ANOVA was performed 
with Tukey’s multiple comparisons test. ****P<0.0001, **P<0.01 
 
A further example is the test of the fluoroquinolones CIP, Moxifloxacin (MOX) and 
Sparfloxacin (SPA), being either complexated with phenanthroline and copper(II) ions 
(proportion 1:1:1) or free.  
Significant differences can be found between the permeation of complex-bound and 
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free fluoroquinolones, whereas complexed fluoroquinolones show slower permeation 
(Fig. 35). This is in agreement with docking simulations of free and complex-bound 
forms showing that free fluoroquinolones have better access to the constriction zone 
of OmpF supporting an enhanced porin-mediated permeability of free 
fluoroquinolones186. It must be mentioned, however, that some fluoroquinolone 
complexes show equal bactericidal activity, which can be explained in two ways: (i) the 
compounds are highly potent, and therefore even extremely low concentrations within 
the bacterium are already sufficient for their activity, or (ii) an alternative active pathway 
exists, as found for P. aeruginosa187. 
 
Figure 35. Assessment of the permeability of free and complex-bound fluoroquinolones. 
Complexes permeate significantly slower than free fluoroquinolones.  Generally, the 
permeation of the complex-bound fluoroquinolones is still faster than the permeation of NOV. 
CIP = Ciprofloxacin, MOX = moxifloxacin, SPA = sparfloxacin, NOV = novobiocin. n=12 from 
3 independent experiments. Two-way ANOVA was performed with Tukey’s multiple 
comparisons test. ****P<0.0001 
 
3.4.8 Permeability-activity relationships in different bacterial strains 
As a further step, we investigated direct associations between in vitro permeability and 
antibacterial activity against Gram-negative bacterial species mentioned in the priority 
list by the World Health Organization188. Therefore, we took reported MICs from the 
EUCAST data base for E. coli, Pseudomonas aeruginosa, Acinetobacter baumannii, 
and Klebsiella pneumoniae, Campylobacter jejuni, Salmonella spp. and Neisseria 
gonorrhoeae189 and compared those to their respective Papp (Fig. 36, Table in appendix 
7.2 “Minimum inhibitory concentrations”). Obviously, there is a general tendency 
throughout all seven investigated species, that compounds with a Papp above 1*10-5 
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cm/s show antibacterial activity, whereas only two to three compounds show activity 
although their Papp is below 1*10-5 cm/s. It is worth mentioning that the two mostly active 
compounds despite their low in vitro permeability are the aminoglycosides kanamycin 
and tobramycin. Aminoglycosides are known for their extraordinary potency, which 
might compensate for their low accumulation190. This circumstance opens the 
perspective for this assay to be not only used for the prediction of in bacterio 
accumulation, it may also serve as a tool to exclude inactive compounds at an early 





Figure 36. Quadrant analysis of in vitro permeability and in bacterio activity 
relationships of Escherichia coli (A), Acinetobacter baumannii (B), and Klebsiella 
pneumoniae (C), and Pseudomonas aeruginosa (D), Campylobacter jejuni (E), 
Salmonella spp. (F) and Neisseria gonorrhoeae (G). Arbitrarily set lines at an apparent 
permeability coefficient (Papp) of 1*10-5 cm/s and a minimum inhibitory concentration (MIC) of 
64 µg/mL demonstrate a high number of cases, where low MIC values are associated with 
high permeability (green area), whereas low in vitro permeability tends to be associated with 
inactivity. Only few points show activity despite low in vitro permeability (red area). Crosses 






A polysaccharide-based membrane model capable to discriminate high from low 
accumulating antibiotics in the Gram-negative bacterium E. coli was developed. Based 
on such rather reductionist approach, structure-permeation relationships could be 
revealed in more clarity. Factors disturbing the analysis of antibiotic permeation such 
as enzymatic degradation or efflux could be excluded. The preparation of the model is 
simple, highly reproducible, extremely cost effective, hazard-free and allows for high-
throughput screening applications on molecules with very different physicochemical 
properties. While uptake studies in bacteria or models thereof are much more 
cumbersome to perform, membrane permeation experiments with this model can be 
automated and deliver accurate results already after 10 min. A strong selectivity of the 
model membrane for charges may not be favorable since E. coli  features significant 
amounts of the porins OmpF – being selective for positively charged – and PhoE – 
being selective for negatively charged molecules.31 Room for further improvements of 
the model other than by introducing local charges for better ion selectivity may consist 
in the use of starches with different ratios of amylose and amylopectin as well as further 
variation of gel concentrations. This might be of particular interest for the creation of 
permeation models for intrinsically more resistant bacterial species such as P. 
aeruginosa, A. baumanii or K. pneumoniae. However, extensive in bacterio 
accumulation data for a model validation with respect to these species are still missing. 
Apart from the introduction of a polysaccharide-based permeation model, we 
elucidated the in bacterio accumulation of representative aminoglycosides and 
sulfonamides. The outstanding predictivity of our rather simple starch-based in vitro 
model, which does not feature any element of active transport, suggests that Gram-
negative uptake of antibiotics is essentially governed by passive transport (e.g. through 
porins). Applying contemporary tools of machine learning to our data set provided 
strong evidence to the impact of molecular characteristics. Complementary to the 
previously suggested “eNTRy” rules, we found that a small set of 7 features was 
sufficient of create a robust machine learning model with good predictivity. 
Prospectively, by refining the composition of the alginate formulation, the described 
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Extracellular vesicles are membrane vesicles constitutively shed by virtually all cells. 
Although their concept can be even traced back as far as to Charles Darwin191, they 
have become a popular focus of research just in recent years. Depending on their 
origin and composition, extracellular vesicles fulfil different purposes, such as cell-to-
cell communication, disposal of unwanted compounds and defence192. For Gram-
negative bacteria three different vesicle types have been reported: i) outer membrane 
vesicles (OMVs)193, ii) inner membrane vesicles194 and iii) outer-inner membrane 
vesicles195,196. 
Since the outer membrane of Gram-negative bacteria appears to be the major delimiter 
of antibiotic permeation, OMVs seem eligible also for their repurposing towards the 
application as a permeation model for drug permeation studies. Although in this 
chapter strong evidence will be provided that the obtained vesicles are outer 
membrane vesicles, I considered it as more appropriate to refer to the biomaterial as 
extracellular vesicles since there is no evidence that other vesicle types were excluded. 
Generally, OMVs are biomaterials, which can be comparatively easy obtained at low 
costs. Their vesicular structure resembles liposomes but they feature a plethora of 
components27 specific for each bacterial strain and species. Omp’s, LPS, 
phospholipids, parts of efflux pumps and TonB-dependent transporters (TBDT) make 
outer membrane vesicles to a favourite candidate to be assessed as an in vitro 
permeation model. Nakae et al.197, Ferreira et al.198 as well as Wang et al.113 employed 
already bacterial membrane vesicles to investigate the outer membrane permeability 
of saccharides or antibiotics, respectively. Their individual advantages and 
disadvantages are mentioned in section 1.4.2 Cell-free assays. As protocols for 
liposomal coating of filter supports exist3, these can be easily adapted to OMVs. It is 
hypothesized that this approach will have advantages compared to the previously 
mentioned approaches, regarding precision, compound diversity, a more authentic 







MultiScreen® 96-well Filter plates with 0.4 µm PCTE membrane and MultiScreen® 96-
well Transport Receiver Plates were obtained from EMD Millipore Corporation 
(Billerica, Ma, USA). Agarose SERVA (research grade) was obtained from SERVA 
Electrophoresis GmbH (Heidelberg, Germany). 1-hexadecanoyl-2-(9Z-octadecenoyl)-
sn-glycero-3-phosphoethanolamine (POPE), 1-hexadecanoyl-2-(9Z-octadecenoyl)- 
sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) (POPG), and 1,1′,2,2′-tetra-(9Z-
octadecenoyl) cardiolipin (sodium salt) (CL) were obtained from Avanti Polar Lipids 
Inc. (Alabaster, AL, USA). Lipoid E80 was kindly donated by Lipoid GmbH 
(Ludwigshafen, Germany). Tetracycline-HCl was obtained from chemodex (St. Gallen, 
Switzerland). Rifampicin was obtained from USBiological (Swampscott, MA, USA). 
novobiocin sodium was from Cayman Chemical Company (Ann Arbor, MI, USA). 
Phosphate buffered saline (pH 7.4) was prepared from dissolution of 0.02M PBS 
tablets without potassium (Genaxxon Bioscience, Ulm, Germany) in 1 L of Milli-Q 
water. Hydrochloric acid and sodiumhydroxide solutions (1 M each) were used from 
Bernd Kraft (Duisburg, Germany). Methanol and Acetonitrile (both HPLC grade) were 
obtained from VWR Chemicals (VWR International S.A.S., Fontenay-sous-Bois, 
France). FluoraldehydeTM (o-phthaldialdehyde reagent solution) was obtained from 
Thermo Fisher Scientific (Waltham, MA, USA). Trichloro acetic acid, tobramycin, 
ciprofloxacin, chloramphenicol, and clindamycin hydrochloride were obtained from 




4.3.1 Bacterial culture 
 
One colony of Escherichia coli BL21 or K-12 MG1655, respectively, was transferred 
into a 100 mL conical flask filled with 20 mL lysogeny broth (LB). After overnight 
incubation at 37°C, 180 rpm the entire broth was transferred to a 1 L conical flask filled 
with 280 mL of LB broth, which was cultured over another 6 nights (37 °C, 180 rpm) 
until isolating the extracellular vesicles. 
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4.3.2 Vesicle isolation  
 
Vesicles were harvested at the death phase (1.2 * 1010 CFU/mL, OD600 = 4.08). 300 
mL of bacterial culture was dispensed into FalconTM tubes and centrifuged for 15 min 
(4°C, 9500 g) using a Hettich Rotina 420 R centrifuge (Andreas Hettich GmbH & Co. 
KG, Tuttlingen, Germany). Following centrifugation, the supernatant was filtered either 
through a 0.20 µm SartoriusTM Minisart® NML or 0.45 µm SartoriusTM Minisart® NY 
syringe filer (Sartorius AG, Göttingen, Germany) The concentration of vesicles was 
done using either ultracentrifugation or a polyethylene glycol (PEG)-mediated 
precipitation method. In the case of ultracentrifugation, the filtrate was equally 
dispensed into 60 mL ultracentrifugation tubes followed by 2h centrifugation at 
100.000g (4°C) using a Beckman Coulter OptimaTM XL-100K Ultracentrifuge 
(Beckman Coulter Corp., Brea, CA, USA). In the case of PEG-precipitation, the filtrate 
was dispensed into 50 mL FalconTM tubes and blended with a 33% (m/m) PEG8000-
sultion in a 4:1 ratio. FalconTM tubes were kept at 4 °C overnight and subsequently 
centrifuged for 30 min at 16,098 g (4°C). The supernatant was discarded and each 
pellet resuspended in 100 µL of PBS (pH7.4). 
4.3.3 Preparation of Liposomes 
 
The preparation of bacteriomimetic and mammalian comparator liposomes was done 
as in the section 2. “A total four-layered Model of the Gram-negative Bacterial 
Envelope” and according to Graef et al.117 In contrast to bacteriomimetic liposomes, 
mammalian comparator liposomes, were prepared from 233 mg Lipoid E80 (egg 
phosphatiylcholine), which were dissolved in 5 mL of a blend of chloroform and 
methanol (3:1). Evaporation, rehydration and extrusion was performed at 50 °C.  
4.3.4. Nanoparticle tracking analysis 
 
Liposomes were diluted 1 in 100.000 and bacterial extracellular membrane vesicles 
were diluted 1 in 10.000 in PBS (pH7.4) before analysis. Each analysis was done in 
triplicates with 30 s per analysis at 25 °C using the Nanosight LM-10 (Malvern 
Instruments Ltd., United Kingdom) equipped with a green laser (532 nm). The camera 
level varied between 12 and 15, while the detection threshold was chosen between 2-
5 accordingly. Data processing was performed by Nanosight 3.1 software (Malvern 





For zetasizing, liposomes were diluted 1 in 1000 and bacterial extracellular membrane 
vesicles were diluted 1 in 100 in PBS (pH7.4) before analysis using dynamic light 
scattering to determine the size and laser doppler micro-electrophoresis for the 




Vesicles of E. coli K-12 MG1655 as well as BL21 were obtained from a one-week liquid 
culture of 300 mL as described before using trichloroacetic acid (TCA) precipitation. 
50 mL of bacteria free EV-containing LB-medium were given to 10 g TCA, followed by 
shaking and incubation in an ice bath for 30 min. After that, the liquid was centrifuged 
for 30 min at 11,000 rpm and 4°C. The supernatant was discarded, and the pellet 
resuspended in 0.5 mL ice cold acetone followed by another centrifugation at 30 min 
at 11,000 rpm. After discarding the supernatant, the pellet was resuspended in 40 µL 
of a blend of PBS and resuspension buffer (RSB, 3 parts PBS to 1 part RSB).  
20 µL of the obtained samples were given to 5 µL sample buffer (15 % (v/v) deionized 
water; 50 % (v/v) 0.5 M Tris-HCl (pH 6.8); 30 % (v/v) glycerol; 10 % (w/v) sodium 
dodecyl sulfate (SDS); 0.02 % (w/v) bromophenol blue, 5 % (v/v) -mercaptoethanol), 
heated to 95 °C, and cooled down in ice.  
A 12 % (w/v) polyacrylamide resolving gel and 5 % stacking gel was prepared. The 
stacking gel was loaded with 20 µL of sample at 60 V. Gel electrophoresis was 
performed at 150 V using a Mini-PROTEAN® Tetra handcast system (both Bio-Rad 
Laboratories GmbH, Feldkirchen, Germany) and a PageRulerTM Unstained Protein 
Ladder (Thermo Fischer Scientific Inc., Waltham, Ma, USA). PierceTM Silver Stain Kit 
(Thermo Fischer Scientific Inc.) was employed for protein detection before 
documenting the results by a Gel Doc EZ System (Bio-Rad Laboratories GmbH). The  
4.3.7 Cryo-TEM of bacterial extracellular membrane vesicles 
 
3 µL of the vesicle suspension were placed onto a S147-4 holey carbon film (Plano, 
Germany), followed by blotting to a thin liquid film for 2 s. Afterwards, samples were 
plunged at T = 108 K into liquid ethane employing a Gatan (Pleasonton, USA) CP3 
Cryo plunge system. Visualization was performed at T = 100 K using a JEOL 
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(Akishima, Japan) JEM-2100 LaB6 TEM operating at an accelerating voltage of 200 
kV at low-dose conditions199. 
4.3.8 Scanning electron microscopy (SEM) of bacterial extracellular membrane 
vesicles 
 
10 µL of vesicles were placed on a silicon wafer and after a brief rest, the wafer was 
gently washed 2 times before staining by phosphotungstic acid. The silicon wafer was 
mounted on aluminium stubs, using double-sided adhesive carbon tape and copper 
grids (Micro to Nano, Netherlands) and let dry overnight at room temperature. Samples 
were then sputtered with gold using a Quorum Q150R ES sputter-coater (Gala 
Instrumente GmbH, Bad Schwalbach, Germany). SEM imaging was facilitated 
employing Zeiss EVO HD15 (Carl Zeiss AG, Jena, Germany) under an acceleration 
voltage of 6 kV, and images were processed with SmartSEM® software (Carl Zeiss 
AG, Jena, Germany).  
 
4.3.9 Coating of filter plate 
 
In the case of bacterial extracellular vesicles, 30 µL of the vesicle suspension were 
given on top of membrane filters of a 96-well filter plate. Afterwards filters were dried 
at 37 °C inside a Memmert UF55 universal oven (fan at 100%). This process was 
repeated for another two times before giving 40 µL of liquefied 0.5 % (w/v) agarose 
solution was given on top. In the case of liposomes, the suspensions were diluted to a 
concentration of 1012 particles/mL. The liposomes were bioprinted onto filters of a 96-
well filter plate (30 µL/well) using a g-code similar to the one used for the starch gel, 
but with some modifications: the piston moved 2x 0.089 mm (E0.089) to extrude overall 
30 µL per layer. After the first coating step was finished, Peltier elements embedded in 
the plate holder dried the coating for 30 min at 60 °C. This coating procedure was 
repeated twice followed by 15 min freezing to -20 °C and heating to 40 °C. The 
obtained phospholipids coatings were covered with 0.5 % (w/v) agarose solution as 
previously described for the extracellular vesicle coating. Prior to permeation studies 
the bottom the coated filter was also coated with a thin film of 0.5 % (w/v) agarose 




4.3.10 SEM of coated filter plate 
 
Membrane filters were coated with bacterial extracellular vesicles as previously 
described. Afterwards they were stripped from the plate and mounted on aluminium 
stubs, using double-sided adhesive carbon tape and let dry overnight at room 
temperature. Samples were then sputtered with gold using a Quorum Q150R ES 
sputter-coater (Gala Instrumente GmbH, Bad Schwalbach, Germany). SEM imaging 
was facilitated employing Zeiss EVO HD15 (Carl Zeiss AG, Jena, Germany) under an 
acceleration voltage of 6 kV, and images were processed with SmartSEM® software 
(Carl Zeiss AG, Jena, Germany).  
 
4.3.11 Permeation studies  
 
The compound permeability was investigated as described in section 3.2.1 
“Assessment of polysaccharide gels”. In brief, coated wells were incubated for 30 min 
with PBS (pH7.4) at 37 °C while shaken at 180 rpm. After incubation, 230 µL of pre-
warmed 200 µM antibiotic donor solution (37°C) replaced the PBS in the respective 
donor wells, while 30 µL were immediately removed and diluted 1:10. The absorbance 
of these dilutions was measured in a receiver plate using a Tecan Infinite® 200 PRO 
(Tecan Trading AG, Maennedorf, Switzerland) plate reader. 300 µL of fresh PBS were 
given into the acceptor wells of the receiver plate followed by absorbance 
measurements. Donor and acceptor plate were reassembled, incubated, and 
disassembled after 10, 20, 30, 45, 60, 90, 120, 150, 180, 210 and 240 min to measure 
the absorbance in the acceptor wells. For substances with insufficient λmax, 220 µL of 
donor solution was given in each donor well. 20 µL were removed and diluted 1 in 10. 
At all time points, samples of 40 µL were drawn, diluted 1 in 5 measured by LC-MS. In 
case of tobramycin samples of 20 µL were drawn and quantified by an o-
phthalaldehyde assay. 200 µL of the commercially available PierceTM Fluoraldehyde 
reagent (Thermo Fisher Scientific) were added to each sample and after an incubation 
at room temperature the fluorescence intensity at 470 nm was measured at an 
excitation wavelength of 360 nm. The removed volume was replaced using fresh PBS 





4.4 Results and Discussion 
 
4.4.1 Optimizing vesicle isolation 
 
Coating of filter plates requires a high number of vesicles. While the production of the 
liposomes can be adjusted with minor effort to achieve rather high concentrations, the 
upscaling of extracellular vesicle production is comparatively difficult. To enhance the 
vesicular yield, the hypervesiculating strain BL21 was chosen and different isolation 
and concentration protocols were studied aiming for an additional increase of yield. It 
is common practice to isolate extracellular vesicles by ultracentrifugation200. This, 
however, is a long lasting and tedious process, especially when also applying density 
gradients. Bearing in mind that our approach does not require high sample purity, PEG 
precipitation201 may also be a legitimate concentration process for extracellular 
vesicles. As shown in Figure 37, the application of PEG precipitation showed indeed a 
substantial increase of vesicle concentration. Filtration of the bacterial culture is an 
essential step towards vesicle isolation. However, small pore sizes, such as the 
required 0.2 µm for sterile filtration may also retain a certain number of extracellular 
vesicles. Therefore, another filter with 0.45 µm pore size was used for extrusion and 
the yields obtained from both filter types compared. In seems indeed that the overall 
number of vesicles is higher, when filtered through a filter membrane with 0.45 µm pore 
size (Fig. 37 A). However, the analysis of the area under the curve does not reveal a 
significant difference (Fig. 37 B). In both cases, a similar distribution pattern appears 
having two larger maxima in the range from 100 to 200 nm, whereas those vesicles 
obtained from membranes with 0.2 µm pore diameter show a slight shift towards larger 
sizes. Another vesicle population is noticeable slightly above 200 nm, regardless if 
which filter was used followed by a subsequent drop in concentration. This size being 
located just around the cut-off of the 0.2 µm filter membrane is surprising at first glance, 
but can allow for different interpretations: i) this population of vesicles is natively shed 
by bacteria, ii) this population actually consists of aggregates of 100 nm sized vesicles, 
and iii) this population is an artefact cause for example by nano-sized air bubbles. ii) 
seems unlikely, especially when considering the size shift, which appears at the first 
maximum, but which is missing at the third. iii) seems unlikely, since the third maximum 
follows the regular decrease of peak height beginning from the two. The little population 
peaks at 300 nm and 320 nm are likely to be artifacts. Further preparative processes 
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were done, however, using the PEG precipitation following filtration through 0.45 µm 
pore size membranes, since it also led to sterile filtrates in the case of E. coli BL21 
(Fig. 37) and enabled for an easier vesicle isolation due to the decreased fluid 
resistance.  
Figure 37. Vesicle yields obtained from different isolation protocols.  Precipitation with 
PEG 8000 leads to significantly higher vesicle concentrations than 2h ultracentrifugation (UC) 
at 100,000 x g (A, B). Although the filtration through a 0.45 µm pores leads to higher 
concentration maxima at lower particles sizes in comparison to filters with 0.2 µm sized pores, 
the overall yield is not significantly different.  Values represent mean ± SE. Significance was 
tested by two-way ANOVA, followed by Tukey’s multiple comparisons test, ****P<0.0001, n = 
9 from 3 independent experiments. 
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4.4.2. Vesicle characterization 
 
Subsequently, particle characteristics of extracellular vesicles obtained with the 
optimized isolation protocol were compared to those of EVs obtained from E. coli 
MG1655 as well as from bacteriomimetic liposomes as used for the total membrane 
model (Fig. 38) and mammalian comparator liposomes, as reported by Graef et al.117.  
Figure 38. Comparison of basic particle properties between bacteriomimetic liposomes 
and EVs of E. coli BL21 and MG1655. Liposomes could be obtained in much higher 
concentrations than EVs (A). EVs of both E. coli strains are similarly sized but are significantly 
smaller than the employed liposomes (B), while the polydispersity index (PdI) is in every case 
high (C). The ζ-potential of all strains is negative, whereas the amount of the ζ-potential for EV 
is much lower than of bacteriomimetic liposomes, but slightly higher than of the mammalian 
comparator liposomes (D). Columns represent mean values ± SD. For A: n= 3-6 for EV E. coli 
BL21 and liposomes, n=2 for EV E. coli MG1655, each from independent experiments. For B, 
C, D: n=6-9 from 2-3 independent experiments. Significance was tested using a one-way 
ANOVA with Tukey’s multiple comparisons test. **P<0.01, ***P<0.001, ****P<0.0001. 
Although the EV yield from E. coli strain BL21 is 10 times higher than from E. coli 
MG1655, it is obvious that in spite of the optimized isolation protocol, this yield is still 
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approximately 15 times lower than of the liposome formulations (Fig. 38 A). This points 
to challenges, when attempting further upscaling approaches. Figure 38 B illustrates 
that the size of EVs from E. coli BL21 and MG1655 is similar, while the EV sizes are 
generally significantly lower than of bacteriomimetic and mammalian comparator 
liposomes, while the polydispersity index (PdI) is not significantly different. Notably, the 
standard deviations of the PdI are rather large and throughout all vesicles above 0.2, 
suggesting a high abundance of different vesicle size populations. Inspecting the ζ-
potential, one can notice that it negative for all measured vesicular structures. While 
the ζ-potential of the EV-isolates from E. coli is almost identical (ca. -8 mV), 
bacteriomimetic liposomes feature a much higher ζ-potential (ca. -25 mV). In contrast, 
the ζ-potential of the mammalian comparator liposomes is particularly low (ca. -2 mV). 
The measured data are plausible. Mammalian comparator liposomes are mainly 
composed of zwitterionic phosphatidylcholine with its quaternary amine at its head 
group. Hence, it has a net charge of zero at physiological pH (7.4). The slightly negative 
value could be caused by little impurities of other phospholipids, such as POPE. 
Although POPE is also predominantly zwitterionic at physiological pH, the ammonium 
moiety at its head group can undergo acid base reaction to a certain extent, leading to 
a small species of negatively charged POPE. The cell envelope of E. coli is known to 
be composed of 10 % phosphatidylglycerol - a negatively charged phospholipid, which 
therefore probably accounts for the measured potential of the two EV types. Apart from 
POPE and POPG, bacteriomimetic liposomes are moreover composed of cardiolipin, 
which features three negative charges per molecule and leads to a far higher ζ-
potential in comparison to the other vesicle structures.  
After showing obvious differences in size and charge between EVs and liposomes, the 
presence of the most abundant outer membrane proteins F and C (OmpF, OmpC) on 
the isolated EVs was investigated using SDS-PAGE. As can be easily observed in 
Figure 39 line 10, a strong band is located just below the 40 kDa mark. This is in 
agreement with the molecular mass of 37 kDa and 36.5 kDa of monomeric OmpF202,203 
or OmpC204,205, respectively. These proteins were already found to be present in high 
amounts on vesicles of other E. coli strains206. Because of the intensity of the band, 
these homologous proteins207 could not be further resolved. OmpF and OmpC usually 






Fig. 39. Band distribution after SDS-PAGE of E. coli K-12 MG1655 and BL21 EV-pellet.  
A) SDS-PAGE after protein isolation by precipitation protocol with trichloroacetic acid. Columns 
3 and 7 show the protein spectrum of E. coli K-12 MG1655 EVs undiluted and diluted 1 in 10, 
respectively. Columns 5 and 9 show the protein spectrum of E. coli BL21 EVs undiluted and 
diluted 1 in 10, respectively. EVs from both strains feature a band just below 40 kDa. This band 
is especially intense for E. coli BL21 EVs and indicates a high abundance of the major outer 
membrane proteins OmpF (37 kDa) and C (36.5 kDa). In contrast to K-12 MG1655 vesicles, 
BL21 EVs feature a much fainter band at ca. 35 Da. This value is characteristic for OmpA171,208. 
B) SDS-PAGE after a standard ultracentrifugation protocol. The aforementioned bands are 
more prominent. Further faint lines between 50 and 70 kDa and between 70 and 100 kDa are 
characteristic for the TonB-dependent receptors BtuB or FhuA, FecA and Fep, respectively171. 
The smear below 30 kDa might have been caused by LPS. 
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A culture of E. coli over one week seems rather long and one may ask, whether after 
this time not only proteins, but also vesicles are still intact. While for the former we 
demonstrated the abundance of relevant proteins by SDS-PAGE, we employed the 
two electron microscopic techniques SEM (Fig. 40 A) and transmission electron 
microscopy (TEM, Fig. 40 B). Both techniques confirm the polydispersity of vesicles 
with a greater abundance of vesicles with a diameter of approximately 100 nm. 
Moreover, both micrographs show the spherical shape.  
In contrast to SEM, the TEM micrograph also reveals the presence of stacked lamellar 
and tube-like structures. Its composition is unclear, but similar shapes could be 
observed previously along with outer membrane vesicles209. Being similarly electron 
dense like the membrane of the extracellular vesicles, it is possible that they are 








 Figure 40. Electron micrographs of EVs from E. coli BL21. Vesicular structures can be 
observed by SEM (A) as well as cryo-TEM (B, red arrows). While objects in the SEM-
micrograph are mostly vesicular, TEM revealed the presence of stacked lamellar structures 
(yellow arrows). 
As there are obviously side products among extracellular vesicles, a purification of 
these vesicles can be achieved by performing size exclusion chromatography (SEC), 
while collecting fractions. Subsequently, a bicinchonic acid (BCA)-assay can be 
employed to find out, which fractions contain vesicles, and which contain impurities. A 
purification of vesicles was indeed possible, as depicted in Figure 41. From fraction 
12-14 a dramatic increase of protein concentration is visible, indicating those fractions 
with extracellular vesicles. In the later fractions, smaller protein particles eluted, which 




Figure 41. Bicinchonic acid assay on SEC fractions obtained from the purification of E. 
coli BL21 EVs. SEC could largely separate EV fractions from fractions containing dissolved 
proteins (A). The highest amount of EV-associated proteins could be obtained at fraction 13 
with a protein concentration of circa 42 µg/mL. 
With the aim to create a model with high throughput, the quick preparation of the model 
is also a crucial factor determining the opportunity to translate this model to industrial 
production. Although SEC can purify vesicles, it also decreases the vesicle 
concentration, as the initial suspension volume of 0.7 mL becomes diluted to circa  
3 mL, while losing some part of the vesicle population. As previously shown in Figure 
38, even non-purified vesicles are clearly lower concentrated than bacterio-mimetic 
liposomes. Hence, omitting the SEC step and coating the non-purified vesicle 
suspension directly on the filter support seemed a justified way when aiming for high 
throughput.  
 
4.4.3. Preparation and characterization of the model 
For the coating of the filter plate with extracellular vesicles, a previously reported 
protocol was chosen117 and further adapted. Electron micrographs were taken using 
SEM to study the layer morphology on top of the filter membrane (Fig. 42). Whereas a 
coating with pure PBS lead to the formation of rugged incoherent structures of large 
crystals (Fig. 42 A), PBS containing EVs lead to the formation of smaller and finer salt 
crystals covered with an amorphous layer (Fig. 42 B). This is expectable, since the 
suspension contains a vast number of vesicles and proteins, which act as seeds for 
crystallization. Further coating with the EV suspension decreases the amount of visible 
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salt crystals and the membrane surface appears more and more amorphous (Fig. 42 
C). Since the yield of vesicle suspension remains with about 700 µL low, a threefold 
and not a six-fold coating was performed for the following studies, to allow for higher 
throughput. Using this approach, 700 µL allowed for the coating of circa 8 wells. 
 
Figure 42. SEM images coated filters following different protocols. While membranes 
coated with plain PBS show an incoherent structure of large salt crystals (A, B), a three-fold 
coating of the membrane with in PBS resuspended extracellular vesicles (EVs) leads to the 
formation of a coherent layer containing longer and smaller crystals (C) but also amorphous 
structures (D). A six-fold coating with the EV suspension leads to a thick, coherent, and largely 
amorphous layer as can be expected for phospholipid vesicles. 
In previous experiments on liposome coated membranes, it turned out that a 
phospholipid coated filter membrane is rather fragile and partially detaches when 
giving aqueous solution on top or shaking in an aqueous environment at elevated heat. 
To reduce this effect, is was necessary to cover this layer and hence protect it from 
mechanical stress. On the other hand, detaching phospholipids do not only float within 
the apical donor compartment but are also able to permeate across the filter support 
into the basolateral acceptor compartment and form agglomerates. These can cause 
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artifacts to the absorbance read of the acceptor compartment. Therefore, it is also 
necessary to seal the basolateral side of the filter membrane in a way that 
phospholipids are retained but the permeation of small antibiotic molecules is not 
affected, which is a challenging task. Having investigated previously systematically the 
permeability of different kinds of hydrogels, it seems self-evident to look at these results 
now from a different perspective, aiming for a formulation, which has the least 
discriminating and diffusion decelerating effect. Among the tested gels, agarose 
formulations (Fig. 15 A) overall yielded the highest permeability coefficients for high 
and low accumulating antibiotics at a comparably low standard deviation. Agarose is 
also favourable in other ways, as it is uncharged and forms gels at very low 
concentrations (>0.1 %, w/v)210. To ensure some degree of gel stability, a 
concentration of 0.5 % (w/v) was selected. In agarose gel electrophoresis 
concentrations of 0.5 % (w/v) are recommended to separate DNA from 1000 bp and 
larger211. Hence, it should not represent a significant barrier to small molecules.  
Having found a gel with low discriminating properties, a combined coating was 
undertaken (Fig. 43) 
 
Figure 43. Sketch about preparation protocol of EV-based membrane model. 30 µL of the 
EV-suspension are pipetted into wells of an MPC4NTR10 filter plate and dried for 1h at 37 °C. 
The procedure was repeated another two times. Subsequently, 40 µL of 0.5 % (w/v) 
prewarmed agarose solution are pipetted into the corresponding wells before letting the 
coating rest at 4 °C overnight. Eventually, a thin film of 0.5 % (w/v) agarose was placed by a 
brush on the downside of the filters. 
The obtained membrane model was then subjected to permeation studies, choosing 
ciprofloxacin, tetracycline, chloramphenicol and nalidixic acid – previously identified to 
be high accumulating in bacterio and the low accumulating representatives 
clindamycin, rifampicin, novobiocin.  
As depicted in Figure 44 and as already previously found in the starch model, 
ciprofloxacin, nalidixic acid and chloramphenicol showed higher permeation than those 
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antibiotics belonging to the low accumulating group. Moreover, on this extracellular 
vesicle-based membrane model, novobiocin, unexpectedly, is the best permeating 
compound among the low accumulating antibiotics, although it is 187 Da “smaller” and 
at physiological pH negatively charged, making it less suitable for Gram-negative 
bacterial transmembrane permeation. In fact, novobiocin even surpasses reportedly 
high accumulating tetracycline as per permeated amounts.  
 
Figure 44. Permeation-time course of seven antibiotics. Ciprofloxacin, chloramphenicol 
and nalidixic acid show a fast increase of permeated amounts, while novobiocin, tetracycline, 
rifampicin and clindamycin enrich less fast in the acceptor compartment. Values represent 
mean permeated amounts ± SE. n  9 from at least 3 independent experiments. 
To assess the accuracy of the model, quadrant plots of in bacterio accumulation and 
in vitro permeability parameters are depicted in Figure 45. As can be expected from 
the previously discussed permeation-time curves (Figure. 44), plotting permeated 
amounts in vitro after 10 min against their respective accumulated amounts in bacterio, 
led to inaccuracy regarding tetracycline, which permeated much lower than can be 
expected from the accumulation data (Figure 45 A). In comparison, as in chapter 3 
discussed, the starch-based assay allowed for a better agreement between 
tetracycline accumulation in bacterio and in vitro permeation.  
Exchanging the permeated amounts for apparent permeability coefficients yielded a 
better match to reported and determined accumulation data (Figure 45 B), however 
with novobiocin and tetracycline showing insignificantly different permeability 
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coefficients. This outcome was compared permeability coefficients obtained from a 
previously reported and slightly modified model based on fused bacteriomimetic 
liposomes and its mammalian comparator model.117 The bacteriomimetic model was 
able to yield matching permeability coefficients to in bacterio permeability in only five 
out of seven cases, with TET and CIP permeating extraordinarily low. A similar 
permeation behaviour of these compounds was noticed for the mammalian comparator 
model. Moreover, the good permeability of CLI did not match with its low in bacterio 
accumulation overall leading to four out of seven correct matches.  
 
Figure 45. Quadrant plots of in bacterio accumulation and in vitro permeability 
parameters. Comparing in bacterio accumulation to in vitro permeation across the 
extracellular vesicle-based model at the respective 10 min time point (A), led to a wrong 
prediction of TET. A higher accuracy could be achieved by plotting in bacterio accumulation at 
10 min against the Papp (B). Papp-values obtained from the bacteriomimetic phospholipid-based 
comparator model led to insufficient discrimination between high-accumulating CIP and TET 
and low-accumulating CLI, RIF and NOV (C) and was only slightly better performing than the 
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mammalian comparator model (D). Values represent mean ± SE. n  9 from at least 3 
independent experiments. Red circles indicate reported in bacterio data80, while blue squares 
represent in bacterio data contributed from a collaboration partner. 
Apart from comparing the in vitro permeation of antibiotics to in bacterio accumulation, 
a comparison of compound permeability through different membrane formulations is 
recommended to discuss the impact of their respective structural features. Therefore,  
permeability coefficients of the extracellular vesicle-based model were compared to 
the aforementioned models, representing either Gram-negative or mammalian 
membranes117 (Fig. 46). By doing so, the comparatively good permeability of 
ciprofloxacin and tetracycline across the EV-based model is striking and indicates an 
OmpF/C-mediated permeation. For the bacteriomimetic and mammalian phospholipid 
models, only compounds with low molecular weight, low flexibility, and low net charge, 
such as nalidixic acid, chloramphenicol and clindamycin were able to permeate 
significantly better than other antibiotics. These results are in nice agreement with 
permeation phenomena observed at a previously four-layered model, as described in 
chapter 2.4.3 “Functional characterization” and reported by Graef et al.94, where 
nalidixic acid and PqsD-inhibitors permeated significantly faster than those with 
molecular weights around or greater than 300 Da. Given that the most abundant 
molecular species of nalidixic acid is its corresponding negatively charged base, its 
high permeability seems surprising. However, the molecule seems internally stabilized 
by a hydrogen bond between the hydrogen of the carboxylic acid group and its 
neighbouring carbonyl oxygen. This still allows nalidixic acid to remain in a substantial 
amount as uncharged species easing the permeation across the membrane model. 
The high permeability of novobiocin obtained with the extracellular vesicle-based 
model may be an artifact. Prospectively, an additional EV-coating step seems 
advantageous to increase the stability of the membrane model. When comparing the 
outcome of the bacteriomimetic and the mammalian comparator model the compound 
permeability of neutral molecules is even more enhanced in the mammalian 
comparator model. A possible explanation can be slightly lower rigidity117. Another 
factor might be its low zeta-potential leading to a lower accumulation of electrolytes 
within the diffuse layer on the membrane surface and hence to a better access of 
molecules to the membrane in general. While the extend of permeability seems 
different the qualitative differences in permeability remain largely the same between 
these two models, indicating that a variation in phospholipid composition may change 
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the general membrane permeability but will rather not change qualitative differences 
in compound permeability. This confirms once again the need for biomaterials, which 
feature additional components, such as porins, for a more accurate prediction of 
antibiotic uptake.  
 
Figure 46. Comparison of apparent permeability coefficients (Papp) obtained from 
different vesicle coatings and antibiotics. Among the employed biomaterials starch is best 
in predicting reportedly high (green area) and low accumulating (red area) antibiotics. A coating 
of EV shows also good performance, however, the high Papp and SD for NOV indicates 
drawbacks of this approach, such as low membrane stability and varying EV quality. 
Phospholipid layers obtained from liposomal fusion favour the permeation of small, flat 
compounds, such as CHL and NXD. These are mostly high accumulating compounds in 
bacterio. However, other high accumulating compounds, which are slightly larger and more 
polar, such as CIP and TET are repelled, indicating a considerably high rate of false negative 
results. Points represent mean Papp ± SE. n = 7-16 from 3-4 experiments. Two-way ANOVA 
with Tukey’s multiple comparisons test was performed. *P<0.05, **P<0.01, ****P<0.0001. 
The impact of the 0.5 % (w/v) agarose coating on the overall compound permeability 
was investigated as in chapter 3.4.2 “Selection of hydrogel” using the small high-
accumulating compounds ciprofloxacin and tetracycline as well as the large low-
accumulating compounds novobiocin and rifampicin. In comparison to the vesicular 
models, permeability coefficients obtained from the pure agarose coating were 
significantly higher than from the phospholipid-based model (Fig. 47).  This gives 
evidence that the phospholipid layer is the permeability-delimiting entity in the 




Figure 47. Permeability coefficients for ciprofloxacin, tetracycline, novobiocin and 
rifampicin obtained from pure agarose 0.5% (w/v), EV or phospholipid coatings. All 
tested antibiotics permeated significantly faster across the agarose gel proving that the 
phospholipid layers are the major delimiter to antibiotic permeability. Points represent mean 
Papp ± SE. n = 7-14 from 3 independent experiments. Two-way ANOVA with Tukey’s multiple 
comparisons test was performed. **P<0.01, ****P<0.0001. 
Subsequently, permeability coefficients of the EV-based model were compared to their 
respective values obtained from the 20 % (w/v) starch gel coating as described in 
chapter 3. “Polysaccharide Gels as Membrane Model”. Notably, permeability 
coefficients of the starch model seemed in better agreement with in bacterio data than 
those obtained from the EV-based model, since all reportedly high-accumulating 
compounds in bacterio lead to higher permeability coefficients than low-accumulating 
antibiotics (Fig. 48). However, also in comparison to the starch assay, ciprofloxacin 
permeates much faster across the EV-based membrane, while nalidixic acid 
permeates similarly fast. This points to a certain selectivity of the model that goes 
beyond simple size exclusions. Yet, the concrete mechanisms behind, still need to be 
elucidated using a larger set of molecules and complementary analytical methods, 




Figure 48. Comparison of permeability data obtained from extracellular vesicle (EV)-
based and 20% (w/v) starch-based membranes. While the EV-based model favoured the 
permeability of the only two high-accumulating drugs chloramphenicol and ciprofloxacin, the 
starch model revealed an increased permeability for all tested high-accumulating antibiotics 
compared to the low-accumulating ones. Points represent mean Papp ± SE. n = 9-16, from 3 
to 4 experiments. Two-way ANOVA was performed with Tukey’s multiple comparisons test. 






Isolating extracellular vesicles of E. coli BL21 using the PEG-precipitation method led 
to a yield sufficient to coat filter supports of a 96-well filter plate and to perform 
permeation studies with a small set of antibiotics. Further increases of the vesicle yield 
could be achieved mechanically by explosive cell lysis212 or French press, by exposure 
of the bacteria to stressors such as antibiotics, depletion of nutrients, media with 
increased acidity or basicity, increased temperature or by genetic modification213. 
There is evidence for the presence of a high abundance of outer membrane proteins, 
especially for the homologs OmpF and OmpC. Permeation studies on the obtained 
membrane models in comparison to plain phospholipid coatings gave support to the 
idea that this presence of proteins has impact on the permeation behaviour of those 
antibiotics which mainly follow the porin-mediated pathway. Compared to the outcome 
of the starch-based membrane model, the EV-based membrane model had an inferior 
performance. This is probably mainly because the EV-based model is very fragile and 
thus susceptible to disintegration and damage. The reason for this is the still 
comparably low yield of extracellular vesicles. Prospectively, larger bacterial cultures 
and certain bacterial stressors will be necessary to enable for higher yield and hence 
higher throughput.  
Western blotting is recommended to give clear evidence to the presence of the 
mentioned outer membrane proteins. With the perspective that TonB-dependent 
receptors are present on the vesicle surface, the model can also be optimized towards 







5. Summary and outlook 
 
Three different filter membrane-based approaches were investigated to study and 
predict the permeation of anti-infectives across the Gram-negative bacterial cell 
envelope in vitro. Each one of these investigated membrane models has advantages 
and disadvantages (Tab. 14). And their suitability depends on the investigator’s 
hypotheses and aims.  
Table 14. Comparison of models presented in this dissertation. 











+ no biohazard 
+ easy handling 
+ robust model 
- tedious preparation 
-  relatively long 
transport studies 
(2.5-4.5h) 











+ quick preparation 
+ low safety 
requirements 
+ automation easy 
+ often fast 
analysis due to 
UV-vis-
spectroscopy 
+ valid results 
already within 1 h 
+ low material 
costs 
- difficult to adapt to 
specific strains 
- passive transport 
only 
- constant transition 













+ adjustable to 
various bacterial 
species and strains 
+ fast analysis 
+ low material 
costs 
+ quick assay 
+ non-infectious 
biomaterial 
- low yield of 
vesicles 











The total envelope model can be valuable when referring to species with much stricter 
delimitation of antibiotic permeation across porins, such as in P. aeruginosa94,214. In 
contrast to E. coli, the permeation of less polar molecules becomes then more 
pronounced215. Results obtained from a simplified coating consisting of bacterio-
mimetic phospholipids as depicted in Figure 46 indicate that probably, the outer 
membrane compartment as part of the total envelope model has negligible barrier 
properties. Hence, a simplified model as previously reported117 would be already 
sufficient and enables for better upscaling and faster production. This model instead of 
being called an “inner membrane” model, should be considered as an “outer 
membrane” model. Although its outward appearance is not comparable to the Gram-
negative outer membrane, its permeation delimiting function strongly suggests this. 
Various reports within the past five decades have given evidence that the outer 
membrane is the major delimiter of antibiotic permeability instead of the inner 
membrane31,44,171,182,216.   
Because of this notion, a hydrogel-based model was developed considering 
hydrophilic compartments of the Gram-negative cell envelope, particularly unspecific 
porins. After a successful automation of the membrane coating, an ambitious validation 
approach was undertaken for this model leading to a good match with accumulation in 
E. coli K-12 MG1655 and giving evidence that the permeation-determining 
physicochemical parameters are similar to those found in E. coli. The simplicity and 
cost efficacy of this model make an implementation also in sparsely equipped 
laboratories possible. Since E. coli K-12 strains are not pathogenic, this model still 
needs evidence that it can predict compound accumulation in clinically more relevant 
strains.   
The extracellular vesicle-based model is potentially more strain specific. The formation 
of a consistent coating despite the low vesicle concentration could be proven.  
Comparing the permeability of a small set of antibiotics to plain phospholipid models 
revealed obvious differences pointing to some degree of porin-mediated permeation 
across the EV-based model. However, the model still requires further investigations 
and characterizations to give conclusive suggestions about its applicability. The data 
set should be extended towards a larger panel of antibiotics, at least as large as the 
one used for the starch hydrogel model. For this, further enhancement of the vesicle 
yield is crucial. At the same time, other extracellular vesicles should be employed, and 
permeability data compared to accumulation in different bacterial strains and species.  
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The shift to 96-wells was, indeed, advantageous, as it led to a more efficient 
performance of experiments and a reduction of material use and thus costs.  
A drawback of all presented filter-based in vitro models is the negligence of active 
transport and self-supported uptake mechanisms. The former way is already exploited 
today217,218 and will become most likely even more important in future. The latter 
mechanism can be attractive, e.g. when looking for uptake mediators (e.g. 
antimicrobial peptides) of novel macromolecular anti-infective classes, especially 
different kinds of nucleic acids (siRNAs, PNAs, LNAs etc.). Especially active transport 
mechanisms appear utterly challenging to establish as a filter membrane-based in vitro 
model. Even the most extensively studied active uptake pathway via TonB-dependent 
transporters is still not entirely understood and depends on a complex interplay 
between different proteins219,220. These proteins will need an authentic environment of 
the entire Gram-negative cell envelope. Although Clifton et al. reported such an 
achievement, even this approach was incomplete120. Hence, as future perspective, the 
field of filter membrane-based models should be left, if active transport should be 
implemented.  
Generally, bacterial assays related to activity and “bacterial bioavailability” must be 
advanced towards higher throughput. This will be the first stage of reducing costs and 
research time. The extensive data generation can lead to a second step, where 
experimental investigation of small homologous series of anti-infectives on well 
characterized in vitro models may become obsolete, because machine learning 
algorithms previously trained on vast data sets will give even faster and comprehensive 
results at minimum requirements to IT infrastructure. Slowly the potential of these 
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7.1 List of antibiotics used to calculate the mean molecular weight and clogD7.4 for each antibiotic class 
 
Antibiotic class Panel 
Aminoglycosides Streptomycin, tobramycin, kanamycin, amikacin 
Penicillins 
Ampicillin, amoxicillin, piperacillin, sultamicillin, 
pivampicillin, bacampicillin 
Cephems Cefuroxime, ceftibuten, flomoxef, cefminox, loracarbef 
Carbapenems 
Imipenem, meropenem, ertapenem, doripenem, 
thienamycin 
Monobactams tabtoxin, aztreonam, nocardicin A, tigemonam 
Fluoroquinolones 
Ciprofloxacin, sparfloxacin, gemifloxacin, garenoxacin, 
clinafloxacin, prulifloxacin 
Tetracyclines 




















































































349.4 -0.60 Y 47.21 4 0.200 5 3 -2.36 0.081 112.73 31.09 10.11 
Aztreonam 
 
N 435.4 0.00 Y 60.09 6 0.200 11 4 -6.12 0.098 201.58 35.3 7.337 
Cefuroxime 
 
N 424.4 0.00 N 60.77 8 0.234 7 3 -4.38 0.083 173.76 29.99 7.732 
Imipenem 
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733.9 0.91 N 105.59 7 0.017 13 5 1.57 0.247 193.91 3.47 1.525 
Sorangicin A 
 




[a] obtained from Chemicalize (ChemAxon, Budapest, Hungary) 
[b] obtained from Molecular Operating Environment (Chemical Computing Group, Montreal, QC, Canada) 
[c] calculated by dividing the sum of double and aromatic bonds by the total number of covalent bonds per molecule 
Min. proj. area: minimum projection area; Rotb: number of rotatable bonds; rel. abund. unsat bonds: relative abundance of unsaturated bonds; 
HBA: number of hydrogen bond acceptors; HBD: number of hydrogen bond donors; Glob: globularity (without preservation of chirality); Pol. surf. 
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822.9 -0.49 N 122.68 5 0.149 14 6 2.87 0.361 220.15 14.20 3.973 
Steroids Fusidic acid 
 




























412.4 -0.20 Y 56.24 1 0.283 8 6 -1.27 0.039 184.17 21.96 3.521 
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7.3 Minimum inhibitory concentrations  











MIC / µg*mL-1 
A. 
baumannii[a] 
MIC / µg*mL-1 
K. 
pneumoniae[a] 
MIC / µg*mL-1 
P. 
aeruginosa[a] 
MIC / µg*mL-1 
C. jejuni[a] 
MIC / µg*mL-1 
Salmonella 
spp.[a] 






Novobiocin 0.82 X x x x x x x 
Amino-
glycosides 
Kanamycin A 0.55 4 x 2 64 x 0.5 x 
Strepto-
mycin 
1.11 8 x 2 x 1 8 x 





2.11 4 x 4 x 4 8 2 
-lactams 
Ampicillin 1.58 2 32 16 x 2 1 0.5 
Aztreonam 1.59 0.032 64 32 4 x 0.064 x 
Cefuroxime 1.37 4 32 2 x x 4 0.064 












1.82 0.016 0.25 0.032 0.125 0.125 0.032 0.002 
Levofloxacin 1.07 0.032 0.125 0.064 0.5 x 0.064 0.008 
Norfloxacin 1.64 x 0.125 0.064 0.5 x x x 
Sparfloxacin 0.62 0.064 x 0.125 0.5 x 0.064 0.008 
Glyco-
peptides 




Clindamycin 1.19 x x x x 0.125 x x 





0.55 x x x x 0.25 x 4 





1.65 x x x x x x x 
Rifamycins Rifampicin 1.00 x 4 x x x x x 









Minocycline 1.10 1 0.5 2 x x x x 
Tetracycline 1.51 2 128 2 x 128 2 2 





0.99 x x x x x x x 
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7.4 G-code for starch membrane printing 
 
G90 
G0 X231.2 Y95.3 Z99.0 F1000 
G91  
G0 X-9.5 Y0 F1000 
G0 X0.4 Y-1.5 F1000 
G90 
G0 Z72.10 F1000  
G91 
T0 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16.1 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.1 F1000 
G0 X-10.8 F1000 
G0 Z-16.2 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.2 F1000 
G0 X-1.8 Y9 F1000 
G0 Z-16.2 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16.2 F1000 
G0 X7.2 F1000 
G0 Z-16.1 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.1 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 




G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000G0 X7.2 F1000G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X-1.8 Y9 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
 G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
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G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16.1 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.1 F1000 
G0 X-10.8 F1000 
G0 Z-16.2 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G0 X1.8 F1000  
G0 Z16.2 F1000 
G0 X-1.8 Y9 F1000 
G0 Z-16.2 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16.2 F1000 
G0 X7.2 F1000 
G0 Z-16.1 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.1 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X-1.8 Y9 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
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G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F100 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16.1 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.1 F1000 
G0 X-10.8 F1000 
G0 Z-16.2 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.2 F1000 
G0 X-1.8 Y9 F1000 
G0 Z-16.2 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16.2 F1000 
G0 X7.2 F1000 
G0 Z-16.1 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.1 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
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G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X-1.8 Y9 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000    
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G0 X1.8 F1000  
G0 Z16 F1000 
G0 X-10.8 F1000 
G0 Z-16.1 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F100 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.1 F1000 
G0 X-10.8 F1000 
G0 Z-16.2 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G0 X1.8 F1000  
G0 Z16.2 F1000 




G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16.2 F1000 
G0 X7.2 F1000 
G0 Z-16.1 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000   
G0 X1.8 F1000 
G0 Z16.1 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 
G0 X7.2 F1000 
G0 Z-16 F1000 
G2 X0 Y-0.00001 I1.9 J0 E0.128 F10  
G2 X0 Y-0.00001 I1.9 J0 E0.128 F1000 
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000  
G2 X0 Y-0.00001 I1.9 J0 F1000 
G0 X1.8 F1000 
G0 Z16 F1000 





7.5 R-code for random forest analysis 
 
# Author: Sanjay Kumar Srikakulam 
# Description: Random forest regression model for predicting the AUC values (column named 'AUC' in 
the input data sheet) using Leave One Out cross validation. 
# Note: Require 'randomforest', 'readxl' and 'caret' libraries to run this script and it expects the input 
excel file (chem_data_for_rf.xlsx)  
# to be available in the current working directory and the sheet containing the data should have the 
name 'data_for_rf_regression'. 
 




# set seed to same values are obtained everytime 
set.seed(6) 
 
# Set current working directory to the current working directory 
setwd(getwd()) 
 
# Checks if input file 'chem_data_for_rf.xlsx' is available in the cuurent working directory, if not raises 
an error output, else will continue with the model creation. 
if(!file.exists("chem_data_for_rf.xlsx")){ 
  cat("\nError: The input file 'chem_data_for_rf.xlsx' does not exist in the current working directory, 
please check! Aborting the script execution.\n") 
  cat("\nInfo: Your current working directory is: ", getwd()) 
} else { 
  # Reading and processing input data and variable initiation 
  chem_data = read_excel("chem_data_for_rf.xlsx", sheet = 'data_for_rf_regression') 
  compound_names = chem_data$compound 
  leave_one_out = NULL 
   
  # Creating data frame to store the feature importance score of all models during the leave one out 
cross validation (CV) 
  variable_importance = setNames(data.frame(matrix(0, ncol =  7)), c("MW", "overall_charge", 
"globularity_non_preserved", "min_projection_area","no_Hbond_donors", "no_Hbond_acceptors", 
"rel_abund_aromatic")) 
   
  # Leave one out CV and prediction with hyperparameters ntree = 100, mtry = 2, maxnodes = 8 
  for (i in compound_names){ 
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    model_rf = randomForest(AUC ~ ., data = chem_data[chem_data$compound!=i,][, -1], ntree = 100, 
mtry = 2, maxnodes = 8, importance = TRUE, type = "regression") 
    leave_one_out[[i]] = predict(model_rf, newdata = chem_data[chem_data$compound==i,][, -1]) 
    variable_importance = rbind(variable_importance, model_rf$importance[, 1]) 
  } 
   
  # Output processing and printing  
  cat("\n******** Root mean squared error (RMSE), R squared (Rsquared) and Mean absolute error 
values (MAE): ********\n") 
  print(caret::postResample(leave_one_out, chem_data$AUC)) 
   
  cat("\n******** Predicted vs Actual/Experimental AUC values: ********\n") 
  print(data.frame("Predicted"= leave_one_out, "Experimental" = chem_data$AUC)) 
   
  cat("\n******** Feature importance values: ********\n") 
  print(data.frame('IncMSE' = sort(colMeans(variable_importance[-1, ])))) 
} 
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“A biomimetic model of the Gram-negative bacterial cell envelope to assess and 
predict the permeation of anti-infectives”, Controlled Release Society (CRS) 
German chapter meeting 2018, Halle (Saale), Germany 
“In vitro modelling approaches to investigate the permeation across the Gram-
negative bacterial cell envelope”, Controlled Release Society (CRS) German 
chapter meeting 2019, Leipzig, Germany 
“Towards an in vitro model for drug transport studies across the Gram-negative 
bacterial cell envelope”, Annual meeting of the international Controlled Release 
Society (CRS) 2019, Valencia, Spain 
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“A Transwell®-based transport model of the Gram-negative cell envelope”, 
Controlled Release Society (CRS) German chapter meeting 2017, Marburg, Germany 
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3.5 years are over. Many ways were walked – some of them turning out to lead to dead 
ends. But is not the PhD about having walked at the end of current ways and having 
continued to pave them yourself? I am grateful that I could follow my desire to be 
creative and help to evolve additional possibilities in the field of infectious research. A 
field, which can be particularly rewarding for pharmacists, since nowhere else drugs 
succeed more in curing patients. Lectures by Prof. Matthias Melzig at Freie Universität 
Berlin made me become aware of this and motivated me to engage more in this field. 
I am grateful for the many people, who I encountered during my time as a PhD student. 
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First of all, I would like to thank Prof. Claus-Michael Lehr for entrusting me with this 
project, for his unshakable belief in its success and the various opportunities to learn 
more about this topic and to present our work and achievements. I also appreciate that 
he is open for unconventional approaches and that he always knows the right 
collaboration partner for every challenge. Furthermore, I am grateful for his help in 
drafting this dissertation and for his advices.  
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I would also like to thank my second intern Sarah Pawusch, who had the bad luck  
to join our team just when the Corona Pandemia-related lock down of the institute 
started. This, however, did neither stop her eagerness to learn about my project nor 
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help me expanding the knowledge.  
Moreover, I want to thank Jessica Fairhall for proofreading this dissertation and giving 
helpful advices.  
I would also like to thank my numerous collaboration partners: Prof. Anna H. Hirsch,  
Walid A. M. Elgaher, Henni-Karoliina Ropponen (, who impressed me a lot with her 
systematic thinking and meticulousness), Prof. Olga Kalinina, Alexander Gress, Sanjay 
K. Srikakulam, Prof. Mark Brönstrup, Mariel Garcia-Riviera, Jerome Kaspar, 
Maximilian Junk, Patrick Christoffel and Prof. Vielhaber, Prof. Carola Meier, Alexander 
Grißmer and Anja Beckmann, Gregor Fuhrmann (,who e.g. suggested the PEG-
mediated precipitation of membrane vesicles and is an excellent organizer of PhD-
seminars!),  Katrin Fuhrmann.  
I also would like to thank my scientific companion, Prof. Rolf Hartmann as well as all 
other members of the doctoral committee.    
I am also particularly grateful for the help of the technicians. Chiara de Rossi introduced 
me to UHPLC, LC-MS and SEM. Her knowledge, experience and her tips in analytics 
have been constantly guiding me. Pascal Paul’s intuition has always been of great 
help, whenever a technical device was not running properly. Although Jana Westhues 
and Petra König did not contribute much to my project I appreciate their ironic 
conversations and their baking talent. Thanks deserves also Annette Boese for being 
mild whenever I forgot the waste service and helping, when I needed quick and 
uncomplicated solutions. Marijas Jurisic introduced me to the handling of the CLSM.  
I, moreover, want to acknowledge all participants of the lung club, who have not been 
mentioned before, especially Cristiane de Souza Carvalho-Wodarz’, Alberto Hidalgo, 
Patrick Carius, Justus Horstmann, Remi Hendrix-Jastrzebski, Carlos Montefusco-
Perreira, Sarah Frisch, Samy Aliyazdi, who contributed with their critical comments and 
their specific expertise. I also highly acknowledge Justus’ and Carlos’ humor, which 
helped to look at my work a bit more laid back and with the necessary little pinch of 
irony. Although not being in the lung club, Brigitta Loretz has also had very helpful 
comments and could always be spoken to when others were off home long ago. Ronald 
Garcia introduced me to stereo microscopy and first of all made me want to spend 
holidays at the Philippines. Sara Menina, Hanzey Yasar and Jing Wang have always 
been helpful in the lab and beyond, which I highly appreciate. Furthermore, Xabier 
Murgia has had many helping advices. Benedikt Huck pointed to important antibiotic 
uptake-related research work, which I so far was not aware of.  Thanks as well to Sarah 
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Nasr and Rebekka Christmann, who made me feel less lonely in the particle lab and 
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much for his guidance into the very different Japanese culture during the ISEV Annual 
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